CA1115584A - Light-sensitive silver halide photographic material containing a tetrazolium compound and a sensitizing dye - Google Patents
Light-sensitive silver halide photographic material containing a tetrazolium compound and a sensitizing dyeInfo
- Publication number
- CA1115584A CA1115584A CA283,717A CA283717A CA1115584A CA 1115584 A CA1115584 A CA 1115584A CA 283717 A CA283717 A CA 283717A CA 1115584 A CA1115584 A CA 1115584A
- Authority
- CA
- Canada
- Prior art keywords
- tetrazolium
- diphenyl
- silver halide
- group
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 silver halide Chemical class 0.000 title claims abstract description 167
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 100
- 239000004332 silver Substances 0.000 title claims abstract description 100
- 239000000463 material Substances 0.000 title claims abstract description 65
- 230000001235 sensitizing effect Effects 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 claims description 29
- 239000010410 layer Substances 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 25
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000008273 gelatin Substances 0.000 claims description 20
- 229920000159 gelatin Polymers 0.000 claims description 20
- 108010010803 Gelatin Proteins 0.000 claims description 18
- 235000019322 gelatine Nutrition 0.000 claims description 18
- 235000011852 gelatine desserts Nutrition 0.000 claims description 18
- 238000012545 processing Methods 0.000 claims description 15
- 150000001450 anions Chemical group 0.000 claims description 11
- 125000003118 aryl group Chemical group 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- ZNVBVIZZKGKHRB-UHFFFAOYSA-N 2-(5-dodecyl-3-phenyl-1H-tetrazol-2-yl)-1,3-benzothiazole Chemical compound N=1C2=CC=CC=C2SC=1N1NC(CCCCCCCCCCCC)=NN1C1=CC=CC=C1 ZNVBVIZZKGKHRB-UHFFFAOYSA-N 0.000 claims description 6
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 6
- 239000011241 protective layer Substances 0.000 claims description 6
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 6
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Chemical compound C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 claims description 5
- RAECFAXTJBDZOD-UHFFFAOYSA-N 2-[5-(2-chlorophenyl)-3-phenyl-1H-tetrazol-2-yl]-1,3-benzothiazole Chemical compound ClC1=CC=CC=C1C1=NN(C=2C=CC=CC=2)N(C=2SC3=CC=CC=C3N=2)N1 RAECFAXTJBDZOD-UHFFFAOYSA-N 0.000 claims description 5
- ZVNPWFOVUDMGRP-UHFFFAOYSA-N 4-methylaminophenol sulfate Chemical compound OS(O)(=O)=O.CNC1=CC=C(O)C=C1.CNC1=CC=C(O)C=C1 ZVNPWFOVUDMGRP-UHFFFAOYSA-N 0.000 claims description 5
- XHIPMTBCWNNSFM-UHFFFAOYSA-N 5-hexyl-2,3-diphenyl-1H-tetrazole Chemical compound N1C(CCCCCC)=NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 XHIPMTBCWNNSFM-UHFFFAOYSA-N 0.000 claims description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- OMPBPIPZACGTHR-UHFFFAOYSA-N 2,3-diphenyl-1H-tetrazole Chemical compound N1C=NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 OMPBPIPZACGTHR-UHFFFAOYSA-N 0.000 claims description 4
- FJMPZWOQMLJCRS-UHFFFAOYSA-N 2,3-diphenyl-1h-tetrazole-5-carbonitrile Chemical compound N1C(C#N)=NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 FJMPZWOQMLJCRS-UHFFFAOYSA-N 0.000 claims description 4
- IXNKNVCYDIVHSA-UHFFFAOYSA-N 2-(4-methylphenyl)-3,5-diphenyl-1h-tetrazole Chemical compound C1=CC(C)=CC=C1N1N(C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)N1 IXNKNVCYDIVHSA-UHFFFAOYSA-N 0.000 claims description 4
- HWLXUQATWPNSAO-UHFFFAOYSA-N 2-[3-(4-methoxyphenyl)-5-phenyl-1H-tetrazol-2-yl]-1,3-benzothiazole Chemical compound C1=CC(OC)=CC=C1N1N(C=2SC3=CC=CC=C3N=2)NC(C=2C=CC=CC=2)=N1 HWLXUQATWPNSAO-UHFFFAOYSA-N 0.000 claims description 4
- DVYWKCIYDKCQGG-UHFFFAOYSA-N 5-(3,4-dimethoxyphenyl)-2-(2-ethoxyphenyl)-3-(4-methoxyphenyl)-1h-tetrazole Chemical compound CCOC1=CC=CC=C1N1N(C=2C=CC(OC)=CC=2)N=C(C=2C=C(OC)C(OC)=CC=2)N1 DVYWKCIYDKCQGG-UHFFFAOYSA-N 0.000 claims description 4
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical group [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 claims description 4
- 239000004305 biphenyl Substances 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- QOIRFXTZHVPXLR-UHFFFAOYSA-N 2,3,5-triphenyl-1h-tetrazole Chemical compound N1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)N=C1C1=CC=CC=C1 QOIRFXTZHVPXLR-UHFFFAOYSA-N 0.000 claims description 3
- UBJIPDGISJLPQU-UHFFFAOYSA-N 2,3-diphenyl-5-thiophen-2-yl-1H-tetrazole Chemical compound N1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)N=C1C1=CC=CS1 UBJIPDGISJLPQU-UHFFFAOYSA-N 0.000 claims description 3
- ASJSXUWOFZATJM-UHFFFAOYSA-N 2-(3,5-diphenyl-1h-tetrazol-2-yl)-4,5-dimethyl-1,3-thiazole Chemical compound S1C(C)=C(C)N=C1N1N(C=2C=CC=CC=2)NC(C=2C=CC=CC=2)=N1 ASJSXUWOFZATJM-UHFFFAOYSA-N 0.000 claims description 3
- BKFGFBHIORTGEL-UHFFFAOYSA-N 3-[4-[2,3-bis[4-(2-carboxyethyl)phenyl]-1H-tetrazol-5-yl]phenyl]propanoic acid Chemical compound C1=CC(CCC(=O)O)=CC=C1N1N(C=2C=CC(CCC(O)=O)=CC=2)N=C(C=2C=CC(CCC(O)=O)=CC=2)N1 BKFGFBHIORTGEL-UHFFFAOYSA-N 0.000 claims description 3
- HTOVSDZGMHMQII-UHFFFAOYSA-N 4-(2,3-diphenyl-1H-tetrazol-5-yl)benzonitrile Chemical compound C1=CC(C#N)=CC=C1C1=NN(C=2C=CC=CC=2)N(C=2C=CC=CC=2)N1 HTOVSDZGMHMQII-UHFFFAOYSA-N 0.000 claims description 3
- KPXPTOUFIZYILY-UHFFFAOYSA-N 4-(2,3-diphenyl-1H-tetrazol-5-yl)pyridine Chemical compound N1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)N=C1C1=CC=NC=C1 KPXPTOUFIZYILY-UHFFFAOYSA-N 0.000 claims description 3
- LPNMSTZIECKPKI-UHFFFAOYSA-N 5-(4-bromophenyl)-3-phenyl-2-(2,4,6-trichlorophenyl)-1H-tetrazole Chemical compound ClC1=CC(Cl)=CC(Cl)=C1N1N(C=2C=CC=CC=2)N=C(C=2C=CC(Br)=CC=2)N1 LPNMSTZIECKPKI-UHFFFAOYSA-N 0.000 claims description 3
- HLQLADJVXUGAKG-UHFFFAOYSA-N 5-ethyl-2,3-diphenyl-1h-tetrazole Chemical compound N1C(CC)=NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 HLQLADJVXUGAKG-UHFFFAOYSA-N 0.000 claims description 3
- TXCKVRLFZFJSDF-UHFFFAOYSA-N 5-methyl-2,3-diphenyl-1h-tetrazole Chemical compound N1C(C)=NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 TXCKVRLFZFJSDF-UHFFFAOYSA-N 0.000 claims description 3
- SCRSUBWYUBGSPK-UHFFFAOYSA-N 5-nitro-2,3-diphenyl-1H-tetrazole Chemical compound N1C([N+](=O)[O-])=NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 SCRSUBWYUBGSPK-UHFFFAOYSA-N 0.000 claims description 3
- HGMHKDIQDVYKON-UHFFFAOYSA-N N-[4-(3,5-diphenyl-1H-tetrazol-2-yl)phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1N1N(C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)N1 HGMHKDIQDVYKON-UHFFFAOYSA-N 0.000 claims description 3
- QRIJAXWENLJOBO-UHFFFAOYSA-N N1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)N=C1C(C(=C1C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=C1C=1N=NNN=1 Chemical compound N1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)N=C1C(C(=C1C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=C1C=1N=NNN=1 QRIJAXWENLJOBO-UHFFFAOYSA-N 0.000 claims description 3
- HLRFVQODVVUZEA-UHFFFAOYSA-N N1N(C=2C=CC=CC=2)N(N2N=CC=CN2)N=C1C1=CC=CC=C1 Chemical compound N1N(C=2C=CC=CC=2)N(N2N=CC=CN2)N=C1C1=CC=CC=C1 HLRFVQODVVUZEA-UHFFFAOYSA-N 0.000 claims description 3
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 125000000732 arylene group Chemical group 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 3
- GXNZYSHGDTVEFI-UHFFFAOYSA-N ethyl 2,3-bis(3-nitrophenyl)-1H-tetrazole-5-carboxylate Chemical compound N1C(C(=O)OCC)=NN(C=2C=C(C=CC=2)[N+]([O-])=O)N1C1=CC=CC([N+]([O-])=O)=C1 GXNZYSHGDTVEFI-UHFFFAOYSA-N 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 claims description 2
- PTXVSDKCUJCCLC-UHFFFAOYSA-N 1-hydroxyindole Chemical group C1=CC=C2N(O)C=CC2=C1 PTXVSDKCUJCCLC-UHFFFAOYSA-N 0.000 claims description 2
- LWTIGYSPAXKMDG-UHFFFAOYSA-N 2,3-dihydro-1h-imidazole Chemical group C1NC=CN1 LWTIGYSPAXKMDG-UHFFFAOYSA-N 0.000 claims description 2
- GCSVNNODDIEGEX-UHFFFAOYSA-N 2-sulfanylidene-1,3-oxazolidin-4-one Chemical group O=C1COC(=S)N1 GCSVNNODDIEGEX-UHFFFAOYSA-N 0.000 claims description 2
- UGWULZWUXSCWPX-UHFFFAOYSA-N 2-sulfanylideneimidazolidin-4-one Chemical group O=C1CNC(=S)N1 UGWULZWUXSCWPX-UHFFFAOYSA-N 0.000 claims description 2
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 claims description 2
- XYVMOLOUBJBNBF-UHFFFAOYSA-N 3h-1,3-oxazol-2-one Chemical group OC1=NC=CO1 XYVMOLOUBJBNBF-UHFFFAOYSA-N 0.000 claims description 2
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 claims description 2
- 125000005874 benzothiadiazolyl group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 2
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical group O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000002971 oxazolyl group Chemical group 0.000 claims description 2
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical group O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 2
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 claims description 2
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 2
- WFTGTFCWWWPJAF-UHFFFAOYSA-N 1-(2,3-diphenyl-1H-tetrazol-5-yl)ethanone Chemical compound N1C(C(=O)C)=NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 WFTGTFCWWWPJAF-UHFFFAOYSA-N 0.000 claims 2
- QACDNZQVHQGFAB-UHFFFAOYSA-N 2-(2,3-diphenyl-1H-tetrazol-5-yl)-1,3-benzoxazole Chemical compound N1=C(C=2OC3=CC=CC=C3N=2)NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 QACDNZQVHQGFAB-UHFFFAOYSA-N 0.000 claims 2
- PRRVATRGEFUPRF-UHFFFAOYSA-N 2-(2,3-diphenyl-1H-tetrazol-5-yl)quinoline Chemical compound N1=C(C=2N=C3C=CC=CC3=CC=2)NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 PRRVATRGEFUPRF-UHFFFAOYSA-N 0.000 claims 2
- KNMZXRUWMYCXSG-UHFFFAOYSA-N 2-[3-(4-methylphenyl)-5-phenyl-1H-tetrazol-2-yl]-1,3-benzothiazole Chemical compound C1=CC(C)=CC=C1N1N(C=2SC3=CC=CC=C3N=2)NC(C=2C=CC=CC=2)=N1 KNMZXRUWMYCXSG-UHFFFAOYSA-N 0.000 claims 2
- FQYLAHZWZVBJMI-UHFFFAOYSA-N 2-[5-(4-chlorophenyl)-3-(4-nitrophenyl)-1H-tetrazol-2-yl]-1,3-benzothiazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1N(C=2SC3=CC=CC=C3N=2)NC(C=2C=CC(Cl)=CC=2)=N1 FQYLAHZWZVBJMI-UHFFFAOYSA-N 0.000 claims 2
- NDQDVFVHOJQAII-UHFFFAOYSA-N 4-[5-(4-nitrophenyl)-3-phenyl-1H-tetrazol-2-yl]phenol Chemical compound C1=CC(O)=CC=C1N1N(C=2C=CC=CC=2)N=C(C=2C=CC(=CC=2)[N+]([O-])=O)N1 NDQDVFVHOJQAII-UHFFFAOYSA-N 0.000 claims 2
- KWEKLFATGLFLST-UHFFFAOYSA-N 5-(furan-2-yl)-2,3-diphenyl-1H-tetrazole Chemical compound N1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)N=C1C1=CC=CO1 KWEKLFATGLFLST-UHFFFAOYSA-N 0.000 claims 2
- BNIUVQHHCJXGHT-UHFFFAOYSA-N N=1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)NC=1CC(C=1C=CC=CC=1)C(C=1C=CC=CC=1)CC=1N=NNN=1 Chemical compound N=1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)NC=1CC(C=1C=CC=CC=1)C(C=1C=CC=CC=1)CC=1N=NNN=1 BNIUVQHHCJXGHT-UHFFFAOYSA-N 0.000 claims 2
- CZWWCTHQXBMHDA-UHFFFAOYSA-N 3h-1,3-thiazol-2-one Chemical group OC1=NC=CS1 CZWWCTHQXBMHDA-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229940123464 Thiazolidinedione Drugs 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 229960004337 hydroquinone Drugs 0.000 claims 1
- COWNFYYYZFRNOY-UHFFFAOYSA-N oxazolidinedione Chemical group O=C1COC(=O)N1 COWNFYYYZFRNOY-UHFFFAOYSA-N 0.000 claims 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 abstract description 8
- 239000000243 solution Substances 0.000 description 55
- 235000013339 cereals Nutrition 0.000 description 31
- 239000000975 dye Substances 0.000 description 31
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 30
- 239000000839 emulsion Substances 0.000 description 27
- 238000011161 development Methods 0.000 description 26
- 231100000202 sensitizing Toxicity 0.000 description 24
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 23
- 239000003795 chemical substances by application Substances 0.000 description 18
- 125000003831 tetrazolyl group Chemical group 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 230000002458 infectious effect Effects 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000084 colloidal system Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- RKOYIQDBENDSSV-UHFFFAOYSA-N 2-(4-iodophenyl)-3,5-diphenyl-1H-tetrazole Chemical compound C1=CC(I)=CC=C1N1N(C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)N1 RKOYIQDBENDSSV-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 229920000058 polyacrylate Polymers 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 238000003672 processing method Methods 0.000 description 5
- ARENMZZMCSLORU-UHFFFAOYSA-N propan-2-yl naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)OC(C)C)=CC=CC2=C1 ARENMZZMCSLORU-UHFFFAOYSA-N 0.000 description 5
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 5
- NIKHKQWWXBDHGC-UHFFFAOYSA-N 2,3-diphenyl-1,3-dihydrotetrazol-3-ium-5-carbonitrile;thiocyanate Chemical compound [S-]C#N.N1C(C#N)=N[NH+](C=2C=CC=CC=2)N1C1=CC=CC=C1 NIKHKQWWXBDHGC-UHFFFAOYSA-N 0.000 description 4
- LTRYTFOYRKRJLU-UHFFFAOYSA-N 5-(3,4-dimethoxyphenyl)-2-(2-ethoxyphenyl)-3-(4-methoxyphenyl)-1,3-dihydrotetrazol-3-ium;chloride Chemical compound [Cl-].CCOC1=CC=CC=C1N1[NH+](C=2C=CC(OC)=CC=2)N=C(C=2C=C(OC)C(OC)=CC=2)N1 LTRYTFOYRKRJLU-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 4
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- XXWAHKICOZTQOW-UHFFFAOYSA-N 1-[2,3-bis(4-ethoxyphenyl)-1H-tetrazol-5-yl]ethanone Chemical compound C1=CC(OCC)=CC=C1N1N(C=2C=CC(OCC)=CC=2)N=C(C(C)=O)N1 XXWAHKICOZTQOW-UHFFFAOYSA-N 0.000 description 3
- IPZIKIFFPGSDIV-UHFFFAOYSA-N 2-(2,3-diphenyl-1,3-dihydrotetrazol-3-ium-5-yl)-1,3-benzoxazole;chloride Chemical compound [Cl-].N1=C(C=2OC3=CC=CC=C3N=2)NN(C=2C=CC=CC=2)[NH+]1C1=CC=CC=C1 IPZIKIFFPGSDIV-UHFFFAOYSA-N 0.000 description 3
- FBCHOEIZLLKXOF-UHFFFAOYSA-N 2-(4-methylphenyl)-3,5-diphenyl-1,3-dihydrotetrazol-3-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC(C)=CC=C1N1[NH+](C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)N1 FBCHOEIZLLKXOF-UHFFFAOYSA-N 0.000 description 3
- BLWMNAXCPBTEKO-UHFFFAOYSA-N 2-[5-(4-chlorophenyl)-2-(4-nitrophenyl)-1,3-dihydrotetrazol-3-ium-3-yl]-1,3-benzothiazole;chloride Chemical compound [Cl-].C1=CC([N+](=O)[O-])=CC=C1N1[NH+](C=2SC3=CC=CC=C3N=2)N=C(C=2C=CC(Cl)=CC=2)N1 BLWMNAXCPBTEKO-UHFFFAOYSA-N 0.000 description 3
- MSOTUIWEAQEETA-UHFFFAOYSA-N 4-octylbenzenesulfonic acid Chemical compound CCCCCCCCC1=CC=C(S(O)(=O)=O)C=C1 MSOTUIWEAQEETA-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- UMGDCJDMYOKAJW-UHFFFAOYSA-N aminothiocarboxamide Natural products NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 3
- VZVHUBYZGAUXLX-UHFFFAOYSA-N azane;azanide;cobalt(3+) Chemical compound N.N.N.[NH2-].[NH2-].[NH2-].[Co+3] VZVHUBYZGAUXLX-UHFFFAOYSA-N 0.000 description 3
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 3
- 150000001661 cadmium Chemical class 0.000 description 3
- 229910052793 cadmium Inorganic materials 0.000 description 3
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 229940105984 diethylhexyl succinate Drugs 0.000 description 3
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 3
- 229940043264 dodecyl sulfate Drugs 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 150000003283 rhodium Chemical class 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- CNHDIAIOKMXOLK-UHFFFAOYSA-N toluquinol Chemical compound CC1=CC(O)=CC=C1O CNHDIAIOKMXOLK-UHFFFAOYSA-N 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 235000020985 whole grains Nutrition 0.000 description 3
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 2
- JZLLHLCEVVEDGF-UHFFFAOYSA-N 1-(2,3-diphenyl-1,3-dihydrotetrazol-3-ium-5-yl)ethanone;chloride Chemical compound [Cl-].[NH2+]1C(C(=O)C)=NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 JZLLHLCEVVEDGF-UHFFFAOYSA-N 0.000 description 2
- DWDWWENTOZPRAA-UHFFFAOYSA-N 2,2-diethyl-3-hexyl-3-sulfobutanedioate;5-ethyl-2,3-diphenyl-1,3-dihydrotetrazol-3-ium Chemical compound N1C(CC)=N[NH+](C=2C=CC=CC=2)N1C1=CC=CC=C1.N1C(CC)=N[NH+](C=2C=CC=CC=2)N1C1=CC=CC=C1.CCCCCCC(C([O-])=O)(S(O)(=O)=O)C(CC)(CC)C([O-])=O DWDWWENTOZPRAA-UHFFFAOYSA-N 0.000 description 2
- LVPFIQLQEJUWCB-UHFFFAOYSA-N 2,2-diethyl-3-hexyl-3-sulfobutanedioic acid Chemical compound CCCCCCC(C(O)=O)(S(O)(=O)=O)C(CC)(CC)C(O)=O LVPFIQLQEJUWCB-UHFFFAOYSA-N 0.000 description 2
- QQYNCBUCYXJFCT-UHFFFAOYSA-N 2,3-diphenyl-1,3-dihydrotetrazol-3-ium;4-octylbenzenesulfonate Chemical compound N1C=N[NH+](C=2C=CC=CC=2)N1C1=CC=CC=C1.CCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1 QQYNCBUCYXJFCT-UHFFFAOYSA-N 0.000 description 2
- CDNHHFDCGUXITF-UHFFFAOYSA-N 2,3-diphenyl-5-[4-(2,4,4-trimethylpentan-2-yloxy)phenyl]-1h-tetrazol-1-ium;chloride Chemical compound [Cl-].C1=CC(OC(C)(C)CC(C)(C)C)=CC=C1C1=NN(C=2C=CC=CC=2)N(C=2C=CC=CC=2)[NH2+]1 CDNHHFDCGUXITF-UHFFFAOYSA-N 0.000 description 2
- OPRFPVHIAQGVQF-UHFFFAOYSA-N 2-(2,3-diphenyl-1,3-dihydrotetrazol-3-ium-5-yl)quinoline;chloride Chemical compound [Cl-].N1=C(C=2N=C3C=CC=CC3=CC=2)NN(C=2C=CC=CC=2)[NH+]1C1=CC=CC=C1 OPRFPVHIAQGVQF-UHFFFAOYSA-N 0.000 description 2
- KYENMFWIKMBWJG-UHFFFAOYSA-N 2-(2,5-diphenyl-1h-tetrazol-1-ium-3-yl)-4,5-dimethyl-1,3-thiazole;chloride Chemical compound [Cl-].S1C(C)=C(C)N=C1N1N(C=2C=CC=CC=2)[NH2+]C(C=2C=CC=CC=2)=N1 KYENMFWIKMBWJG-UHFFFAOYSA-N 0.000 description 2
- BXGXSMJZSIIHJM-UHFFFAOYSA-N 2-(3,5-diphenyl-1h-tetrazol-1-ium-2-yl)-1h-triazine;octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC([O-])=O.N1C=CC=NN1N1N(C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)[NH2+]1 BXGXSMJZSIIHJM-UHFFFAOYSA-N 0.000 description 2
- PXQRJXAUOHSZPF-UHFFFAOYSA-N 2-(3,5-diphenyl-1h-tetrazol-1-ium-2-yl)-1h-triazine;sulfate Chemical compound [O-]S([O-])(=O)=O.N1C=CC=NN1N1N(C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)[NH2+]1.N1C=CC=NN1N1N(C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)[NH2+]1 PXQRJXAUOHSZPF-UHFFFAOYSA-N 0.000 description 2
- QDVIEADSFRNGLY-UHFFFAOYSA-N 2-(5-dodecyl-3-phenyl-1h-tetrazol-1-ium-2-yl)-1,3-benzothiazole;bromide Chemical compound [Br-].N1C(CCCCCCCCCCCC)=N[NH+](C=2SC3=CC=CC=C3N=2)N1C1=CC=CC=C1 QDVIEADSFRNGLY-UHFFFAOYSA-N 0.000 description 2
- FEGBZZCTJZRSJQ-UHFFFAOYSA-N 2-[2-(4-methoxyphenyl)-5-phenyl-1,3-dihydrotetrazol-3-ium-3-yl]-1,3-benzothiazole;chloride Chemical compound [Cl-].C1=CC(OC)=CC=C1N1[NH+](C=2SC3=CC=CC=C3N=2)N=C(C=2C=CC=CC=2)N1 FEGBZZCTJZRSJQ-UHFFFAOYSA-N 0.000 description 2
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- XHFJGLIQDYVTSE-UHFFFAOYSA-N 4-(5-methyl-2-phenyl-1h-tetrazol-1-ium-3-yl)phenol;chloride Chemical compound [Cl-].N1C(C)=N[NH+](C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 XHFJGLIQDYVTSE-UHFFFAOYSA-N 0.000 description 2
- XKAKMCNHHNUUGN-UHFFFAOYSA-N 4-(5-methyl-3-phenyl-1H-tetrazol-2-yl)phenol Chemical compound N1C(C)=NN(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 XKAKMCNHHNUUGN-UHFFFAOYSA-N 0.000 description 2
- UWXJPFCATNGVAS-UHFFFAOYSA-N 5-(furan-2-yl)-2,3-diphenyl-1h-tetrazol-1-ium;chloride Chemical compound [Cl-].N1N(C=2C=CC=CC=2)[NH+](C=2C=CC=CC=2)N=C1C1=CC=CO1 UWXJPFCATNGVAS-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- UKKKYZUMSIRVGR-UHFFFAOYSA-N CC(C)OS(C1=CC=CC2=CC=CC=C12)(=O)=O.C(C=C1)=CC=C1C1=NN(C2=CC=CC=C2)N(C2=CC=CC=C2)N1 Chemical compound CC(C)OS(C1=CC=CC2=CC=CC=C12)(=O)=O.C(C=C1)=CC=C1C1=NN(C2=CC=CC=C2)N(C2=CC=CC=C2)N1 UKKKYZUMSIRVGR-UHFFFAOYSA-N 0.000 description 2
- WDCHPTNIKQRFNV-UHFFFAOYSA-N CC(C)OS(C1=CC=CC2=CC=CC=C12)(=O)=O.CC1=NN(C(C=C2)=CC=C2O)N(C2=CC=CC=C2)N1 Chemical compound CC(C)OS(C1=CC=CC2=CC=CC=C12)(=O)=O.CC1=NN(C(C=C2)=CC=C2O)N(C2=CC=CC=C2)N1 WDCHPTNIKQRFNV-UHFFFAOYSA-N 0.000 description 2
- HMWXMHQVMJUHOK-UHFFFAOYSA-N CC(C)OS(C1=CC=CC2=CC=CC=C12)(=O)=O.ClC(C=C1Cl)=CC(Cl)=C1N1N=C(C(C=C2)=CC=C2Br)NN1C1=CC=CC=C1 Chemical compound CC(C)OS(C1=CC=CC2=CC=CC=C12)(=O)=O.ClC(C=C1Cl)=CC(Cl)=C1N1N=C(C(C=C2)=CC=C2Br)NN1C1=CC=CC=C1 HMWXMHQVMJUHOK-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229910021612 Silver iodide Inorganic materials 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229940101006 anhydrous sodium sulfite Drugs 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000002216 antistatic agent Substances 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 2
- 239000012964 benzotriazole Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical class OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 239000006224 matting agent Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- QOUPOTMFXXDUBF-UHFFFAOYSA-N methyl sulfate;5-nitro-2,3-diphenyl-1,3-dihydrotetrazol-3-ium Chemical compound COS([O-])(=O)=O.N1C([N+](=O)[O-])=N[NH+](C=2C=CC=CC=2)N1C1=CC=CC=C1 QOUPOTMFXXDUBF-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- KPEWKUNOQLFQPB-UHFFFAOYSA-N n-[4-(3,5-diphenyl-1,3-dihydrotetrazol-3-ium-2-yl)phenyl]acetamide;dodecyl sulfate Chemical compound CCCCCCCCCCCCOS([O-])(=O)=O.C1=CC(NC(=O)C)=CC=C1N1[NH+](C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)N1 KPEWKUNOQLFQPB-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 229940045105 silver iodide Drugs 0.000 description 2
- 229940001482 sodium sulfite Drugs 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 2
- 229960000943 tartrazine Drugs 0.000 description 2
- 239000004149 tartrazine Substances 0.000 description 2
- 235000012756 tartrazine Nutrition 0.000 description 2
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
- LUMLZKVIXLWTCI-NSCUHMNNSA-N (e)-2,3-dichloro-4-oxobut-2-enoic acid Chemical compound OC(=O)C(\Cl)=C(/Cl)C=O LUMLZKVIXLWTCI-NSCUHMNNSA-N 0.000 description 1
- NNVNAJGCZFCILW-UHFFFAOYSA-N 1'-methylspiro[3,4-dihydrochromene-2,4'-piperidine]-4-amine;hydrochloride Chemical compound Cl.C1CN(C)CCC21OC1=CC=CC=C1C(N)C2 NNVNAJGCZFCILW-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- ODIRBFFBCSTPTO-UHFFFAOYSA-N 1,3-selenazole Chemical compound C1=C[se]C=N1 ODIRBFFBCSTPTO-UHFFFAOYSA-N 0.000 description 1
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical group O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 description 1
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 1
- KVVCFVUUHKDIST-UHFFFAOYSA-N 1-[2,3-bis(4-ethoxyphenyl)-1,3-dihydrotetrazol-3-ium-5-yl]ethanone;chloride Chemical compound [Cl-].C1=CC(OCC)=CC=C1N1[NH+](C=2C=CC(OCC)=CC=2)N=C(C(C)=O)N1 KVVCFVUUHKDIST-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- WLDWSGZHNBANIO-UHFFFAOYSA-N 2',5'-Dihydroxyacetophenone Chemical compound CC(=O)C1=CC(O)=CC=C1O WLDWSGZHNBANIO-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- LNOBZXNCABUBKK-UHFFFAOYSA-N 2,3,5-triphenyltetrazolium Chemical compound C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 LNOBZXNCABUBKK-UHFFFAOYSA-N 0.000 description 1
- PKDBCJSWQUOKDO-UHFFFAOYSA-M 2,3,5-triphenyltetrazolium chloride Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 PKDBCJSWQUOKDO-UHFFFAOYSA-M 0.000 description 1
- XIWRQEFBSZWJTH-UHFFFAOYSA-N 2,3-dibromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1Br XIWRQEFBSZWJTH-UHFFFAOYSA-N 0.000 description 1
- DBCKMJVEAUXWJJ-UHFFFAOYSA-N 2,3-dichlorobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Cl)=C1Cl DBCKMJVEAUXWJJ-UHFFFAOYSA-N 0.000 description 1
- YZDIUKPBJDYTOM-UHFFFAOYSA-N 2,5-diethylbenzene-1,4-diol Chemical compound CCC1=CC(O)=C(CC)C=C1O YZDIUKPBJDYTOM-UHFFFAOYSA-N 0.000 description 1
- GPASWZHHWPVSRG-UHFFFAOYSA-N 2,5-dimethylbenzene-1,4-diol Chemical compound CC1=CC(O)=C(C)C=C1O GPASWZHHWPVSRG-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
- PVCNLAYTIPAXMG-UHFFFAOYSA-N 2-(4-methylphenyl)-3,5-diphenyl-1,3-dihydrotetrazol-3-ium;4-octylbenzenesulfonate Chemical compound CCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC(C)=CC=C1N1[NH+](C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)N1 PVCNLAYTIPAXMG-UHFFFAOYSA-N 0.000 description 1
- WXHVQMGINBSVAY-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-tert-butylphenol Chemical compound CC(C)(C)C1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 WXHVQMGINBSVAY-UHFFFAOYSA-N 0.000 description 1
- HIGSPBFIOSHWQG-UHFFFAOYSA-N 2-Isopropyl-1,4-benzenediol Chemical compound CC(C)C1=CC(O)=CC=C1O HIGSPBFIOSHWQG-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- REFDOIWRJDGBHY-UHFFFAOYSA-N 2-bromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1 REFDOIWRJDGBHY-UHFFFAOYSA-N 0.000 description 1
- HINXRUYNUJLKSX-UHFFFAOYSA-N 2-hexadecyl-5-methylbenzene-1,4-diol Chemical compound CCCCCCCCCCCCCCCCC1=CC(O)=C(C)C=C1O HINXRUYNUJLKSX-UHFFFAOYSA-N 0.000 description 1
- HEOTXEZZCRFNMW-UHFFFAOYSA-N 2-methyl-5-octadecan-2-ylbenzene-1,4-diol Chemical compound CCCCCCCCCCCCCCCCC(C)C1=CC(O)=C(C)C=C1O HEOTXEZZCRFNMW-UHFFFAOYSA-N 0.000 description 1
- YBMTWYWCLVMFFD-UHFFFAOYSA-N 3-methylbutyl 3,4,5-trihydroxybenzoate Chemical compound CC(C)CCOC(=O)C1=CC(O)=C(O)C(O)=C1 YBMTWYWCLVMFFD-UHFFFAOYSA-N 0.000 description 1
- MDWVSAYEQPLWMX-UHFFFAOYSA-N 4,4'-Methylenebis(2,6-di-tert-butylphenol) Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 MDWVSAYEQPLWMX-UHFFFAOYSA-N 0.000 description 1
- MVVFUAACPKXXKJ-UHFFFAOYSA-N 4,5-dihydro-1,3-selenazole Chemical compound C1CN=C[Se]1 MVVFUAACPKXXKJ-UHFFFAOYSA-N 0.000 description 1
- QROGOPRRETUDKB-UHFFFAOYSA-N 4-butyl-2-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol Chemical compound CC(C)(C)C1=CC(CCCC)=CC(N2N=C3C=C(Cl)C=CC3=N2)=C1O QROGOPRRETUDKB-UHFFFAOYSA-N 0.000 description 1
- CMGDVUCDZOBDNL-UHFFFAOYSA-N 4-methyl-2h-benzotriazole Chemical compound CC1=CC=CC2=NNN=C12 CMGDVUCDZOBDNL-UHFFFAOYSA-N 0.000 description 1
- UWSMKYBKUPAEJQ-UHFFFAOYSA-N 5-Chloro-2-(3,5-di-tert-butyl-2-hydroxyphenyl)-2H-benzotriazole Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(N2N=C3C=C(Cl)C=CC3=N2)=C1O UWSMKYBKUPAEJQ-UHFFFAOYSA-N 0.000 description 1
- BQCIJWPKDPZNHD-UHFFFAOYSA-N 5-bromo-2h-benzotriazole Chemical compound C1=C(Br)C=CC2=NNN=C21 BQCIJWPKDPZNHD-UHFFFAOYSA-N 0.000 description 1
- INVVMIXYILXINW-UHFFFAOYSA-N 5-methyl-1h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one Chemical compound CC1=CC(=O)N2NC=NC2=N1 INVVMIXYILXINW-UHFFFAOYSA-N 0.000 description 1
- RFZVUKSHEUPSMN-UHFFFAOYSA-N 5-methyl-2,3-diphenyl-1,3-dihydrotetrazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C(C)=NN(C=2C=CC=CC=2)N1C1=CC=CC=C1 RFZVUKSHEUPSMN-UHFFFAOYSA-N 0.000 description 1
- XPAZGLFMMUODDK-UHFFFAOYSA-N 6-nitro-1h-benzimidazole Chemical compound [O-][N+](=O)C1=CC=C2N=CNC2=C1 XPAZGLFMMUODDK-UHFFFAOYSA-N 0.000 description 1
- ORZRMRUXSPNQQL-UHFFFAOYSA-N 6-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2C=NNC2=C1 ORZRMRUXSPNQQL-UHFFFAOYSA-N 0.000 description 1
- BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical compound C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- BMFMQGXDDJALKQ-BYPYZUCNSA-N Argininic acid Chemical compound NC(N)=NCCC[C@H](O)C(O)=O BMFMQGXDDJALKQ-BYPYZUCNSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- QKNBDDVDXCGXFF-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C(#N)C1=CC=C(C=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1.C(#N)C1=CC=C(C=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C(#N)C1=CC=C(C=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1.C(#N)C1=CC=C(C=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1 QKNBDDVDXCGXFF-UHFFFAOYSA-N 0.000 description 1
- UOBJEIJPXWSARQ-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C(C)(=O)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1.C(C)(=O)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C(C)(=O)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1.C(C)(=O)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1 UOBJEIJPXWSARQ-UHFFFAOYSA-N 0.000 description 1
- SHKWYTCZHDJMDZ-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C(C)OC(=O)C1=NN(N([NH2+]1)C1=CC(=CC=C1)[N+](=O)[O-])C1=CC(=CC=C1)[N+](=O)[O-].C(C)OC(=O)C1=NN(N([NH2+]1)C1=CC(=CC=C1)[N+](=O)[O-])C1=CC(=CC=C1)[N+](=O)[O-] Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C(C)OC(=O)C1=NN(N([NH2+]1)C1=CC(=CC=C1)[N+](=O)[O-])C1=CC(=CC=C1)[N+](=O)[O-].C(C)OC(=O)C1=NN(N([NH2+]1)C1=CC(=CC=C1)[N+](=O)[O-])C1=CC(=CC=C1)[N+](=O)[O-] SHKWYTCZHDJMDZ-UHFFFAOYSA-N 0.000 description 1
- DPJWUSQTAQVATA-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C1(=CC=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C1=CC=CC=C1.C1(=CC=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C1(=CC=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C1=CC=CC=C1.C1(=CC=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C1=CC=CC=C1 DPJWUSQTAQVATA-UHFFFAOYSA-N 0.000 description 1
- NCVZNVGPSWGOBD-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C1(=CC=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C1=NC2=CC=CC=C2C=C1.C1(=CC=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C1=NC2=CC=CC=C2C=C1 Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C1(=CC=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C1=NC2=CC=CC=C2C=C1.C1(=CC=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C1=NC2=CC=CC=C2C=C1 NCVZNVGPSWGOBD-UHFFFAOYSA-N 0.000 description 1
- CEJPPHXNJONTIG-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C1(=CC=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C=1OC2=C(N1)C=CC=C2.C2(=CC=CC=C2)N2[NH2+]C(=NN2C2=CC=CC=C2)C=2OC1=C(N2)C=CC=C1 Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.C1(=CC=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C=1OC2=C(N1)C=CC=C2.C2(=CC=CC=C2)N2[NH2+]C(=NN2C2=CC=CC=C2)C=2OC1=C(N2)C=CC=C1 CEJPPHXNJONTIG-UHFFFAOYSA-N 0.000 description 1
- JMWRNNRNNURNAS-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.COC=1C=C(C=CC1OC)C1=NN(N([NH2+]1)C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OCC.COC=1C=C(C=CC1OC)C1=NN(N([NH2+]1)C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OCC Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.COC=1C=C(C=CC1OC)C1=NN(N([NH2+]1)C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OCC.COC=1C=C(C=CC1OC)C1=NN(N([NH2+]1)C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OCC JMWRNNRNNURNAS-UHFFFAOYSA-N 0.000 description 1
- ARZXQRYCRPNZIW-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.O1C(=CC=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1.O1C(=CC=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.O1C(=CC=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1.O1C(=CC=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1 ARZXQRYCRPNZIW-UHFFFAOYSA-N 0.000 description 1
- WFSFAKJORWGNLS-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.S1C(=CC=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1.S1C(=CC=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.S1C(=CC=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1.S1C(=CC=C1)C1=NN(N([NH2+]1)C1=CC=CC=C1)C1=CC=CC=C1 WFSFAKJORWGNLS-UHFFFAOYSA-N 0.000 description 1
- RRJBRQJCZMJZQZ-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.S1C(=NC2=C1C=CC=C2)N2[NH2+]C(=NN2C2=CC=C(C=C2)C)C2=CC=CC=C2.S2C(=NC1=C2C=CC=C1)N1[NH2+]C(=NN1C1=CC=C(C=C1)C)C1=CC=CC=C1 Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.S1C(=NC2=C1C=CC=C2)N2[NH2+]C(=NN2C2=CC=C(C=C2)C)C2=CC=CC=C2.S2C(=NC1=C2C=CC=C1)N1[NH2+]C(=NN1C1=CC=C(C=C1)C)C1=CC=CC=C1 RRJBRQJCZMJZQZ-UHFFFAOYSA-N 0.000 description 1
- VGMWGMAHZMGLQD-UHFFFAOYSA-N C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.S1C(=NC2=C1C=CC=C2)N2[NH2+]C(=NN2C2=CC=CC=C2)C2=C(C=CC=C2)Cl.S2C(=NC1=C2C=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C1=C(C=CC=C1)Cl Chemical compound C(C)C(C(C(=O)[O-])CCCCCC)(C(=O)[O-])CC.S1C(=NC2=C1C=CC=C2)N2[NH2+]C(=NN2C2=CC=CC=C2)C2=C(C=CC=C2)Cl.S2C(=NC1=C2C=CC=C1)N1[NH2+]C(=NN1C1=CC=CC=C1)C1=C(C=CC=C1)Cl VGMWGMAHZMGLQD-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- IUWBPTDPBVIOOI-UHFFFAOYSA-N Cc1nc2ncnn2c(O)c1Br Chemical compound Cc1nc2ncnn2c(O)c1Br IUWBPTDPBVIOOI-UHFFFAOYSA-N 0.000 description 1
- 101000654316 Centruroides limpidus Beta-toxin Cll2 Proteins 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- NIPMJVLJVGQZRB-UHFFFAOYSA-N Cl[IH]Br Chemical compound Cl[IH]Br NIPMJVLJVGQZRB-UHFFFAOYSA-N 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- RPWFJAMTCNSJKK-UHFFFAOYSA-N Dodecyl gallate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 RPWFJAMTCNSJKK-UHFFFAOYSA-N 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- DPSKVWTXACOIJH-UHFFFAOYSA-N O.O.O.O.O.O.O.O.O.O.S(=S)(=O)([O-])[O-].[NH4+].[NH4+] Chemical compound O.O.O.O.O.O.O.O.O.O.S(=S)(=O)([O-])[O-].[NH4+].[NH4+] DPSKVWTXACOIJH-UHFFFAOYSA-N 0.000 description 1
- ISLYUUGUJKSGDZ-UHFFFAOYSA-N OC1=CC=NC2=NC=NN12 Chemical compound OC1=CC=NC2=NC=NN12 ISLYUUGUJKSGDZ-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 229910001513 alkali metal bromide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 1
- 229910001864 baryta Inorganic materials 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- AMTXUWGBSGZXCJ-UHFFFAOYSA-N benzo[e][1,3]benzoselenazole Chemical compound C1=CC=C2C(N=C[se]3)=C3C=CC2=C1 AMTXUWGBSGZXCJ-UHFFFAOYSA-N 0.000 description 1
- KXNQKOAQSGJCQU-UHFFFAOYSA-N benzo[e][1,3]benzothiazole Chemical compound C1=CC=C2C(N=CS3)=C3C=CC2=C1 KXNQKOAQSGJCQU-UHFFFAOYSA-N 0.000 description 1
- WMUIZUWOEIQJEH-UHFFFAOYSA-N benzo[e][1,3]benzoxazole Chemical compound C1=CC=C2C(N=CO3)=C3C=CC2=C1 WMUIZUWOEIQJEH-UHFFFAOYSA-N 0.000 description 1
- 150000001565 benzotriazoles Chemical class 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- IFVTZJHWGZSXFD-UHFFFAOYSA-N biphenylene Chemical group C1=CC=C2C3=CC=CC=C3C2=C1 IFVTZJHWGZSXFD-UHFFFAOYSA-N 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- CODNYICXDISAEA-UHFFFAOYSA-N bromine monochloride Chemical compound BrCl CODNYICXDISAEA-UHFFFAOYSA-N 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- ZUIVNYGZFPOXFW-UHFFFAOYSA-N chembl1717603 Chemical compound N1=C(C)C=C(O)N2N=CN=C21 ZUIVNYGZFPOXFW-UHFFFAOYSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 125000002603 chloroethyl group Chemical group [H]C([*])([H])C([H])([H])Cl 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004802 cyanophenyl group Chemical group 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- BAKCDOQBCGHVRG-UHFFFAOYSA-N dioxido-oxo-sulfanylidene-$l^{6}-sulfane;2,3-diphenyl-1h-tetrazol-1-ium Chemical compound [O-]S([O-])(=O)=S.N1C=N[NH+](C=2C=CC=CC=2)N1C1=CC=CC=C1.N1C=N[NH+](C=2C=CC=CC=2)N1C1=CC=CC=C1 BAKCDOQBCGHVRG-UHFFFAOYSA-N 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 239000000555 dodecyl gallate Substances 0.000 description 1
- 235000010386 dodecyl gallate Nutrition 0.000 description 1
- 229940080643 dodecyl gallate Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N hydroquinone methyl ether Natural products COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 125000006303 iodophenyl group Chemical group 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 230000007775 late Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- ZAKLKBFCSHJIRI-UHFFFAOYSA-N mucochloric acid Natural products OC1OC(=O)C(Cl)=C1Cl ZAKLKBFCSHJIRI-UHFFFAOYSA-N 0.000 description 1
- QQPSGKLPTFKHCN-UHFFFAOYSA-N n-(4-benzamido-2,5-dihydroxyphenyl)benzamide Chemical compound OC=1C=C(NC(=O)C=2C=CC=CC=2)C(O)=CC=1NC(=O)C1=CC=CC=C1 QQPSGKLPTFKHCN-UHFFFAOYSA-N 0.000 description 1
- QHEPZDDANRVQLQ-UHFFFAOYSA-N n-[4-(3,5-diphenyl-1,3-dihydrotetrazol-3-ium-2-yl)phenyl]acetamide;chloride Chemical compound [Cl-].C1=CC(NC(=O)C)=CC=C1N1[NH+](C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)N1 QHEPZDDANRVQLQ-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229920006289 polycarbonate film Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- IYKVLICPFCEZOF-UHFFFAOYSA-N selenourea Chemical compound NC(N)=[Se] IYKVLICPFCEZOF-UHFFFAOYSA-N 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- FZHLWVUAICIIPW-UHFFFAOYSA-M sodium gallate Chemical compound [Na+].OC1=CC(C([O-])=O)=CC(O)=C1O FZHLWVUAICIIPW-UHFFFAOYSA-M 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 150000003459 sulfonic acid esters Chemical class 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- CBDKQYKMCICBOF-UHFFFAOYSA-N thiazoline Chemical compound C1CN=CS1 CBDKQYKMCICBOF-UHFFFAOYSA-N 0.000 description 1
- RBRCCWBAMGPRSN-UHFFFAOYSA-N thieno[2,3-d][1,3]thiazole Chemical compound S1C=NC2=C1C=CS2 RBRCCWBAMGPRSN-UHFFFAOYSA-N 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 125000005323 thioketone group Chemical group 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/06—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with non-macromolecular additives
- G03C1/08—Sensitivity-increasing substances
- G03C1/10—Organic substances
- G03C1/12—Methine and polymethine dyes
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/06—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with non-macromolecular additives
- G03C1/067—Additives for high contrast images, other than hydrazine compounds
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- General Physics & Mathematics (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE:
A light-sensitive silver halide photographic material to be treated with a hydroquinones-containing developing solution. This material comprises a support and at least one hydrophilic colloidal layer coated thereon which contains silver halide grains having an average grain size of 0.05 to 1.5 µ, a tetrazolium compound and a sensitizing dye.
A light-sensitive silver halide photographic material to be treated with a hydroquinones-containing developing solution. This material comprises a support and at least one hydrophilic colloidal layer coated thereon which contains silver halide grains having an average grain size of 0.05 to 1.5 µ, a tetrazolium compound and a sensitizing dye.
Description
The present invention relates to a novel light-sensitive silver halide photographic material and the processing method therefor. Particularly, it relates to a novel lith type ligh-t-sensitive silver halide photographic material for obtaining a photographic image with an especially high contrast, high sharpness and high resolving power, and to the processlng method therefor.
More particularly, it relates to a novel light-sensitive silver halide photographic material which is applicable advantageously to a light-sensitive silver halide photographic ``
material with a high contrast suitable for forming a dot- or line-image on a lith (printing) light-sensitive silver halide material or a copying light-sensitive material, as well as to the processing method therefor.
It has been known to form a photographic image with an extremely high contrast by using some kind of a light-sensitive silver halide photographic material.
It has been known, for example, to obtain a high contrast image, e.g. a line- or do-t-image by treating, with an alkaline hydroquinones developing solution containing sulfite ions in a very low concentration, a light-sensitive-material which comprises a silver halide emulsion containing silver chlo-ride in a high content (at least more than 50 mole %) and further containing silver iodide less than 5 mole ~, the grains of which emulsion being minute ~average grain size; ca. 0.3 ~), uniform in size and shape, and the grain size distribution thereof being narrow. The above-mentioned kind of light-sensitive silver halide material is known as the lith type light-sensitive material.
In printing, there is usually required such a process as to convert a con~inuous gradation original to a dot image;
More particularly, it relates to a novel light-sensitive silver halide photographic material which is applicable advantageously to a light-sensitive silver halide photographic ``
material with a high contrast suitable for forming a dot- or line-image on a lith (printing) light-sensitive silver halide material or a copying light-sensitive material, as well as to the processing method therefor.
It has been known to form a photographic image with an extremely high contrast by using some kind of a light-sensitive silver halide photographic material.
It has been known, for example, to obtain a high contrast image, e.g. a line- or do-t-image by treating, with an alkaline hydroquinones developing solution containing sulfite ions in a very low concentration, a light-sensitive-material which comprises a silver halide emulsion containing silver chlo-ride in a high content (at least more than 50 mole %) and further containing silver iodide less than 5 mole ~, the grains of which emulsion being minute ~average grain size; ca. 0.3 ~), uniform in size and shape, and the grain size distribution thereof being narrow. The above-mentioned kind of light-sensitive silver halide material is known as the lith type light-sensitive material.
In printing, there is usually required such a process as to convert a con~inuous gradation original to a dot image;
- 2 -that is a process to convert the densities of the continuous gradation to a predetermined numbered assembly of dots respec-tively having areas o~ the same densities but proportional in size to the densities of the continuous gradation. In order to carry out this, the lith type light-sensitive material is subjected to development, after photographing the original image through a cross- or contact-screen, to form the dot image on the light-sensitive material.
For this purpose there has been employed a light-sensitive silver halide photographic material containing a silver halide emulsion, the grains of which being minute and being uni-form in size and shape. Even when this kind of a light-sensitive silver halide photographic material is employed, the intermediate density region (undesirable continuous gradation parts) is reproduced, beside the maximum density region and the minimum one (fog), when the material is processed with a standard black and white developing solution. The intermediate densit~v reyion or the so-called flinge, undesirable for producing a printing plate and makes the dot qualit~ worse.
There has heretofore been employed the lith type light-sensitive material also for the reproduction of a line image.
For the same reason, however, there have been obtained images having at best the ~-value of 5 - 6 of the characteristic curve, which value is lower than 7 - 9 required for forming the desirable line-image, if the standard black and white developincJ solution is employed. In order to avoid this, there has been employed, as mentioned above, a specific developing solution called " infec-tious developing solution." It is indispensablel however, to maintain the sulfite concentration in the infectious developing solution as low as possible to obtain a high con-trast image, but such the developing solution is very poor in storability because of the low concentration o~ the sul~ite so that this have caused a big trouble in printing business. Every effort has been made, however, to improve the storability. Nevertheless, such efforts have not been so successful. As a result, an ordinary developing solution for a continuous gradation, such as Metol/hydroquinone or phenidone/hydroquinone developing solution which is excellent in the storability, is recommended for processing the light-sensitive materials. However there has been known no method capable of obtaining a dot image with a good dot quality, by using such the developing solution.
It is, therefore, the primary object of the invention to provide a novel light-sensitive silver halide photographic material and the processing method thereof to obtain a high contrast silver image.
It is another object of the invention to provide a lith type light-sensitive silver halide material ~eing dye-sensitized and having a great development stability containing a tetrazolium compound suitable for obtaining a dot- or line-image.
It is still another object of the invention to provide a novel processing method of the above-mentioned lith type light-sensitive silver halide material to obtain a high contrast black and silver image, especially a dot- or line-image.
The inventors have found, after extensive studies to attain the above-mentioned objects, that the object can be attained by processing a lith type light-sensitive silver halide photo-graphic material containing, in a hydrophilic colloidal layer silver halide grains having a narrow grain size distribution, a tetrazolium compound and a sensitizing dye, after exposure, with a developing solution containing a hydro~uinones developing agent as a maln developing agent.
In accordance with the invention, there can be formed a superior line- or dot-image~ without employing the infectious development, by processing a light-sensitive silver halide photographic material having (coated on a support, at least one hydrophilic colloidal layer which comprises light-sensitive silver halide grains having an average grain size of 0.05 - 1.5 and at least 75~ of the total grains being within a range of 0.6 - 1.4 times iarger than the average grain size) a tetrazolium compound and a sensitizing dye, after the image exposure, with a hydroquinones-containing developing solution.
According to a preferred embodiment of the invention, there is obtained a high contrast silver image with a development stability and a superior reproducibility of the line image by processing a light-sensitive silver halide pho-tographic material containing silver halide grains having the above-mentioned grain size and the distribution thereof (hereinafter referred to as the silver halide of the invention), a diffusible tetrazolium compound and a sensitizing dye, after the image exposure, with a hydro-quinones-containing developing solution.
According to another preferred embodiment of the invention, there is obtained a dot-image ~half tone image) with a superior development stability and a superior dot quality by developing a light-sensitive silver halide photographic material containing the silver halide of the invention and a non-diffusible tetrazolium compound and a sensitizing dye, after the image exposure through a contact screen, with the Metol/hydroquinone developing solution (hereinafter referred to as the MQ developing solution) or with the phenidone-hydroquinone developing solution (hereinafter referred to as the PQ developing solution) which are .. i .
famous and polular for the black and white developing solution.
It can not be expected fxom heretofore known techniques that the high contrast line- or dot-image could be obtained without employing -the infectious developing solution.
As explained above, the tetrazolium compounds include non-diffusible and diffusi~le ones. The term "non-diffusible tetrazolium compound" means a compound which does not dissolve from the light-sensitive material to the developing solution during the development. In other words, the compound does not dissolve in a concentration of several ~, preferably not more than 2%, when a yelatin layer containing the compound is dipped for 10 minutes in an aqueous solution at 20 - 40C having the same ion strength and pH-value as those of the developing solution.
The representative tetrazolium compounds employed in the invention include the following compounds repres~nted by the general formulae:
R~ N R3 ( )n-l N~ c~N (I) _ R2 _ R4- ~ - N - D I 1l 5 2 (~) n-l N~C~ ~C~ (II) R8_ ~ _ I Rg R10-NI 1l Rll 2 (~) n-l C~ ~C/ (III) E t In the above formulae, Rl, R3, R4, R5, 8' 9 10 and Rll each represent a group selected from an aryl group such as a phenyl group (e.g. phenyl, tolyl, hydroxyphenyl, carboxyphenyl, aminophenyl or mercaptophenyl, carboxyethyl, nitrophenyl, ethoxyphenyl, iodophenyl, methoxyphenyl, cyano-phenyl, acetoamidophenyl, etc.), a naphtyl group (e.g. an ~-naphtyl, ~-naphtyl, hydroxynaphthyl, carboxynaphthyl or amino-naphthyl, etc.); and a heterocyclic group (e.g. a thiadiazolyl, benzothiadiazolyl, oxazolyl, pyrimidinyl or pyridyl group, 2,5-dimethyl thiazolyl, etc.); the groups can advantageously containan electron sharing group capable of forming a metal chelate or a complex such as primary, secondary, tertiary amino, oxime, thioether, keto, thioketo, hydroxyl, mercapto, carboxyl, sulfo, phospho, and al~oxyl; R2, R6 and R7 represent each a group selected from an aryl group such as a phenyl group and a naphthyl group, a heterocyclic group, an alkyl group (e.g. methyl, ethyl, propyl, butyl, mercaptomethyl or mercaptoethyl and a carboxyalkyl group such as methoxycarbonyl or ethoxycarbonyl), hydroxyl, carboxyl or the salt thereof, an amino group (e.g. amino, e`thyl-amino or anilino), mercapto, nitro and hydrogeni D represents adivalent aromatic group; E represents a group sele~te~ from an alkylene group, an arylene group and an aralkylene group; X is anion; and n is 1 or 2, provided that the compound forms an intra-molecular salt when n is 1.
In the above formula, the divalent aromatic group for E
is preferably an arylene group (e.g. phenylene, alkoxy-substituted phenylene such as methoxy-substituted phenylene, naphtylene diphenylene, etc.) or a divalent aromatic heterocyclic group. ;~
The following are typical examples oE the cationic moieties of the tetra~olium compounds represented by the formula but not intended to limit the tetrazolium compound thereof.
(1) 2-(Benzothiazol-2-yl)-3-phenyl-5-dodecyl-2H-tetrazolium (2) 2,3-Diphenyl-5-(4-t-octyl~xyphenyl)-2H-tetrazolium
For this purpose there has been employed a light-sensitive silver halide photographic material containing a silver halide emulsion, the grains of which being minute and being uni-form in size and shape. Even when this kind of a light-sensitive silver halide photographic material is employed, the intermediate density region (undesirable continuous gradation parts) is reproduced, beside the maximum density region and the minimum one (fog), when the material is processed with a standard black and white developing solution. The intermediate densit~v reyion or the so-called flinge, undesirable for producing a printing plate and makes the dot qualit~ worse.
There has heretofore been employed the lith type light-sensitive material also for the reproduction of a line image.
For the same reason, however, there have been obtained images having at best the ~-value of 5 - 6 of the characteristic curve, which value is lower than 7 - 9 required for forming the desirable line-image, if the standard black and white developincJ solution is employed. In order to avoid this, there has been employed, as mentioned above, a specific developing solution called " infec-tious developing solution." It is indispensablel however, to maintain the sulfite concentration in the infectious developing solution as low as possible to obtain a high con-trast image, but such the developing solution is very poor in storability because of the low concentration o~ the sul~ite so that this have caused a big trouble in printing business. Every effort has been made, however, to improve the storability. Nevertheless, such efforts have not been so successful. As a result, an ordinary developing solution for a continuous gradation, such as Metol/hydroquinone or phenidone/hydroquinone developing solution which is excellent in the storability, is recommended for processing the light-sensitive materials. However there has been known no method capable of obtaining a dot image with a good dot quality, by using such the developing solution.
It is, therefore, the primary object of the invention to provide a novel light-sensitive silver halide photographic material and the processing method thereof to obtain a high contrast silver image.
It is another object of the invention to provide a lith type light-sensitive silver halide material ~eing dye-sensitized and having a great development stability containing a tetrazolium compound suitable for obtaining a dot- or line-image.
It is still another object of the invention to provide a novel processing method of the above-mentioned lith type light-sensitive silver halide material to obtain a high contrast black and silver image, especially a dot- or line-image.
The inventors have found, after extensive studies to attain the above-mentioned objects, that the object can be attained by processing a lith type light-sensitive silver halide photo-graphic material containing, in a hydrophilic colloidal layer silver halide grains having a narrow grain size distribution, a tetrazolium compound and a sensitizing dye, after exposure, with a developing solution containing a hydro~uinones developing agent as a maln developing agent.
In accordance with the invention, there can be formed a superior line- or dot-image~ without employing the infectious development, by processing a light-sensitive silver halide photographic material having (coated on a support, at least one hydrophilic colloidal layer which comprises light-sensitive silver halide grains having an average grain size of 0.05 - 1.5 and at least 75~ of the total grains being within a range of 0.6 - 1.4 times iarger than the average grain size) a tetrazolium compound and a sensitizing dye, after the image exposure, with a hydroquinones-containing developing solution.
According to a preferred embodiment of the invention, there is obtained a high contrast silver image with a development stability and a superior reproducibility of the line image by processing a light-sensitive silver halide pho-tographic material containing silver halide grains having the above-mentioned grain size and the distribution thereof (hereinafter referred to as the silver halide of the invention), a diffusible tetrazolium compound and a sensitizing dye, after the image exposure, with a hydro-quinones-containing developing solution.
According to another preferred embodiment of the invention, there is obtained a dot-image ~half tone image) with a superior development stability and a superior dot quality by developing a light-sensitive silver halide photographic material containing the silver halide of the invention and a non-diffusible tetrazolium compound and a sensitizing dye, after the image exposure through a contact screen, with the Metol/hydroquinone developing solution (hereinafter referred to as the MQ developing solution) or with the phenidone-hydroquinone developing solution (hereinafter referred to as the PQ developing solution) which are .. i .
famous and polular for the black and white developing solution.
It can not be expected fxom heretofore known techniques that the high contrast line- or dot-image could be obtained without employing -the infectious developing solution.
As explained above, the tetrazolium compounds include non-diffusible and diffusi~le ones. The term "non-diffusible tetrazolium compound" means a compound which does not dissolve from the light-sensitive material to the developing solution during the development. In other words, the compound does not dissolve in a concentration of several ~, preferably not more than 2%, when a yelatin layer containing the compound is dipped for 10 minutes in an aqueous solution at 20 - 40C having the same ion strength and pH-value as those of the developing solution.
The representative tetrazolium compounds employed in the invention include the following compounds repres~nted by the general formulae:
R~ N R3 ( )n-l N~ c~N (I) _ R2 _ R4- ~ - N - D I 1l 5 2 (~) n-l N~C~ ~C~ (II) R8_ ~ _ I Rg R10-NI 1l Rll 2 (~) n-l C~ ~C/ (III) E t In the above formulae, Rl, R3, R4, R5, 8' 9 10 and Rll each represent a group selected from an aryl group such as a phenyl group (e.g. phenyl, tolyl, hydroxyphenyl, carboxyphenyl, aminophenyl or mercaptophenyl, carboxyethyl, nitrophenyl, ethoxyphenyl, iodophenyl, methoxyphenyl, cyano-phenyl, acetoamidophenyl, etc.), a naphtyl group (e.g. an ~-naphtyl, ~-naphtyl, hydroxynaphthyl, carboxynaphthyl or amino-naphthyl, etc.); and a heterocyclic group (e.g. a thiadiazolyl, benzothiadiazolyl, oxazolyl, pyrimidinyl or pyridyl group, 2,5-dimethyl thiazolyl, etc.); the groups can advantageously containan electron sharing group capable of forming a metal chelate or a complex such as primary, secondary, tertiary amino, oxime, thioether, keto, thioketo, hydroxyl, mercapto, carboxyl, sulfo, phospho, and al~oxyl; R2, R6 and R7 represent each a group selected from an aryl group such as a phenyl group and a naphthyl group, a heterocyclic group, an alkyl group (e.g. methyl, ethyl, propyl, butyl, mercaptomethyl or mercaptoethyl and a carboxyalkyl group such as methoxycarbonyl or ethoxycarbonyl), hydroxyl, carboxyl or the salt thereof, an amino group (e.g. amino, e`thyl-amino or anilino), mercapto, nitro and hydrogeni D represents adivalent aromatic group; E represents a group sele~te~ from an alkylene group, an arylene group and an aralkylene group; X is anion; and n is 1 or 2, provided that the compound forms an intra-molecular salt when n is 1.
In the above formula, the divalent aromatic group for E
is preferably an arylene group (e.g. phenylene, alkoxy-substituted phenylene such as methoxy-substituted phenylene, naphtylene diphenylene, etc.) or a divalent aromatic heterocyclic group. ;~
The following are typical examples oE the cationic moieties of the tetra~olium compounds represented by the formula but not intended to limit the tetrazolium compound thereof.
(1) 2-(Benzothiazol-2-yl)-3-phenyl-5-dodecyl-2H-tetrazolium (2) 2,3-Diphenyl-5-(4-t-octyl~xyphenyl)-2H-tetrazolium
(3) 2,3,5-Triphenyl-2EI-tetrazolium
(4) 2,3,5-Tri(p-carboxyethylphenyl)-2II--tetrazolium t5) 2-(Benzothiazol-2-yl)-3-phenyl-5-(o-chlorophenyl)-2H-tetrazolium (6) 2,3-Diphenyl-2H-tetrazolium (7) 2,3-Diphenyl-5-methyl-2H-tetrazolium :
(8) 3-(p-Hydroxyphenyl)-5-methyl-2-phenyl-2H-tetrazolium (9) 2,3-Diphenyl-5-ethyl-2H-tetrazolium (10) 2,3-Diphenyl-5-n-hexyl-2H-tetrazolium (11) 5-Cyano-2,3-diphenyl-2H-tetrazolium (12) 2-(genzothiazol-2-yl)-5-phenyl-3-(4-tolyl)-2H-tetrazolium (13) 2-(Benzothiazol-2-yl)-5-(4-chlorophenyl)-3-(4-nitrophenyl) 2H-tetrazolium (14) 5-Ethoxycarbonyl-2,3-di(3-nitrophenyl)-2H-tetrazolium (15) 5-Acetyl-2,3-di(p-ethoxyphenyl)-2H-tetrazolium (16) 2,5-Diphenyl-3-(p-tolyl)-2H-tetrazolium (17) 2,5-Diphenyl-3-(p-iodophenyl)-2H-tetrazolium (18) 2,3-Diphenyl-5-(p-diphenyl)-2H-tetrazolium~
(19) 5-(p-Bromophenyl)-2-phenyl-3-(2,4,6-trichlorophenyl)-2H-tetrazolium (20) 3-(p-Hydroxyphenyl)-5-(p-nitrophenyl)-2-phenyl-21I-tetrazolium (21) 5-(3,4-Dimethoxyphenyl)-3-(2-ethoxyphenyl)-2-(4-methoxy-phenyl)-2H-tetrazolium (22) 5-(4-Cyanophenyl)-2,3-diphenyl-2H-tetrazolium ~23) 3-(p-Acetamidophenyl)-2,5-diphenyl-2H-tetrazolium t24) 5-~cetyl-2,3-diphenyl-2H-tetrazolium (25) 5-(Fur-2-yl)-2,3-diphenyl-2EI-tetrazolium ~26) 5-(Thien-2-yl)-2,3-diphenyl-2H-tetrazolium t27) 2,3-Diphenyl-5-(pyrid-4-yl)-2H-tetrazolium (28) 2,3-Diphenyl-5-(quinol-2-yl)-2EI-tetrazolium (29) 2,3-Diphenyl-5-(benzoxazol-2-yl)-2I~-tetrazollum (30) 2,3-Diphenyl-5-nitro-2H-tetrazolium ~31) 2,2',3,3'-Tetraphenyl-5,5'-1,4-butylene-d.i-(2H-tetrazolium) (32) 2,2',3,3'-Tetraphenyl-5,5'-p-phenylene-di-(2~-tetrazolium) (33) 2-(~,5-Dimethylthiazol-2-yl)-3,5-diphenyl-2EI-tetrazolium (34) 3,5-Diphenyl-2-(triazin-2-yl)-2H-tetrazolium ~35) 2-(Benzothiazol-2-yl)-3-(4-methoxyphenyl)-5-phenyl-2H-tetrazolium (36) 2,5-Diphenyl-3-~-naphthyl-2H-tetrazolium (37) 3,3'-(3,3'-Dimethoxy-4,~'-diphenylene)-2,2',5,5'-tetraphenyl-di-(2H-tetrazolium) As the anion moiety, there can be mentioned, e.g. a : halogen ion, a thiosulfate anion, a su.lfate anion, a thiocyanate anion, an alkylsulfate anion, a nitrate anion, an acetate anion, a lower alkyl benzenesulfonate anion for the diffusible tetra~
zolium compound and higher alkylbenzene-sulEonate anion such as p-dodecylbenzenesulfonate anion, a higher alkylsulfate anion such as laurylsulfate anion, a dialkylsulfosuccinate anion such as di~2-ethylhexylsulfosuccinate anion, a polyether alcohol sulfate anion such as cetylpolyethenoxysulfate anion, a higher fatty acid anion such as stearic acid anion, and a polymer having :
acid radicals such as polyacrylate anion for the non-diffusible tetraozlium compound.
Most typical examples of the compounds of the invention are as follow:
._ g _ ~5~ ~
1] Diffusible tetrazolium compound (1) 2,3,5-Triphenyl-2H-tetrazolium chloride (2) 2,3,5-Tri(p-carboxyethylph~nyl)-2II-tetrazoliu~ iodide (3) 2-(Benzothiazol-2-yl)-3-phenyl-S-(o-chlorophenyl)-211-tetrazolium bromide (4) 2,3-Diphenyl-2H-tetrazolium thiosulfate
(8) 3-(p-Hydroxyphenyl)-5-methyl-2-phenyl-2H-tetrazolium (9) 2,3-Diphenyl-5-ethyl-2H-tetrazolium (10) 2,3-Diphenyl-5-n-hexyl-2H-tetrazolium (11) 5-Cyano-2,3-diphenyl-2H-tetrazolium (12) 2-(genzothiazol-2-yl)-5-phenyl-3-(4-tolyl)-2H-tetrazolium (13) 2-(Benzothiazol-2-yl)-5-(4-chlorophenyl)-3-(4-nitrophenyl) 2H-tetrazolium (14) 5-Ethoxycarbonyl-2,3-di(3-nitrophenyl)-2H-tetrazolium (15) 5-Acetyl-2,3-di(p-ethoxyphenyl)-2H-tetrazolium (16) 2,5-Diphenyl-3-(p-tolyl)-2H-tetrazolium (17) 2,5-Diphenyl-3-(p-iodophenyl)-2H-tetrazolium (18) 2,3-Diphenyl-5-(p-diphenyl)-2H-tetrazolium~
(19) 5-(p-Bromophenyl)-2-phenyl-3-(2,4,6-trichlorophenyl)-2H-tetrazolium (20) 3-(p-Hydroxyphenyl)-5-(p-nitrophenyl)-2-phenyl-21I-tetrazolium (21) 5-(3,4-Dimethoxyphenyl)-3-(2-ethoxyphenyl)-2-(4-methoxy-phenyl)-2H-tetrazolium (22) 5-(4-Cyanophenyl)-2,3-diphenyl-2H-tetrazolium ~23) 3-(p-Acetamidophenyl)-2,5-diphenyl-2H-tetrazolium t24) 5-~cetyl-2,3-diphenyl-2H-tetrazolium (25) 5-(Fur-2-yl)-2,3-diphenyl-2EI-tetrazolium ~26) 5-(Thien-2-yl)-2,3-diphenyl-2H-tetrazolium t27) 2,3-Diphenyl-5-(pyrid-4-yl)-2H-tetrazolium (28) 2,3-Diphenyl-5-(quinol-2-yl)-2EI-tetrazolium (29) 2,3-Diphenyl-5-(benzoxazol-2-yl)-2I~-tetrazollum (30) 2,3-Diphenyl-5-nitro-2H-tetrazolium ~31) 2,2',3,3'-Tetraphenyl-5,5'-1,4-butylene-d.i-(2H-tetrazolium) (32) 2,2',3,3'-Tetraphenyl-5,5'-p-phenylene-di-(2~-tetrazolium) (33) 2-(~,5-Dimethylthiazol-2-yl)-3,5-diphenyl-2EI-tetrazolium (34) 3,5-Diphenyl-2-(triazin-2-yl)-2H-tetrazolium ~35) 2-(Benzothiazol-2-yl)-3-(4-methoxyphenyl)-5-phenyl-2H-tetrazolium (36) 2,5-Diphenyl-3-~-naphthyl-2H-tetrazolium (37) 3,3'-(3,3'-Dimethoxy-4,~'-diphenylene)-2,2',5,5'-tetraphenyl-di-(2H-tetrazolium) As the anion moiety, there can be mentioned, e.g. a : halogen ion, a thiosulfate anion, a su.lfate anion, a thiocyanate anion, an alkylsulfate anion, a nitrate anion, an acetate anion, a lower alkyl benzenesulfonate anion for the diffusible tetra~
zolium compound and higher alkylbenzene-sulEonate anion such as p-dodecylbenzenesulfonate anion, a higher alkylsulfate anion such as laurylsulfate anion, a dialkylsulfosuccinate anion such as di~2-ethylhexylsulfosuccinate anion, a polyether alcohol sulfate anion such as cetylpolyethenoxysulfate anion, a higher fatty acid anion such as stearic acid anion, and a polymer having :
acid radicals such as polyacrylate anion for the non-diffusible tetraozlium compound.
Most typical examples of the compounds of the invention are as follow:
._ g _ ~5~ ~
1] Diffusible tetrazolium compound (1) 2,3,5-Triphenyl-2H-tetrazolium chloride (2) 2,3,5-Tri(p-carboxyethylph~nyl)-2II-tetrazoliu~ iodide (3) 2-(Benzothiazol-2-yl)-3-phenyl-S-(o-chlorophenyl)-211-tetrazolium bromide (4) 2,3-Diphenyl-2H-tetrazolium thiosulfate
(5) 2,3-Diphenyl-5-methyl-2H-tetrazolium chloride
(6) 3~(p-Hydroxyphenyl)-5-methyl-2-phenyl-2H--tetrazolium sulfate 10 (7) 2,3-Diphenyl-5-ethyl-2~ tetrazolium chloride ~8) 2,3-Diphenyl-S n-hexyl-2EI-tetrazolium chloride (9) 5-Cyano-2,3-diphenyl-2H-tetrazolium thiocyanate (10) 2-(Benzothiazol-2-yl)-5-phenyl-3-(4-tolyl)-2~1-tetrazolium chloride (11) 2-(Benzothiazol-2-yl)-5-(4-chlorophenyl)-3-(4-nitrophenyl)-2H-tetrazolium chloride (12) 5-Ethoxycarbonyl-2,3-di(3-nitrophenyl)-2EI-tetrazolium bromide (13) 5-Acetyl-2,3-di(p-ethoxyphenyl)-2H-tetrazolium chloride 20 (14) 2,5-Diphenyl-3-(p-tolyl)-2H-tetrazolium methylsulfate (15) 2,5-Diphenyl-3-(p-iodophenyl)-2EI-tetrazolium chlorlde (16) 2,3-Diphenyl-5-(p-diphenyl)-2H-tetrazolium chloride (17) 5-(p-Bromophenyl)-2-phenyl-3-(2,~,6-trichlorophenyl)-2H-te-trazolium chloride (18) 3-(p-Hydroxyphenyl)-5-methyl-2-phenyl-2H-tetrazolium chloride (19) 5-(3,4-Dimethoxyphenyl)-3-(2-ethoxyphenyl)-2-(4-methoxy-phenyl)-2H-tetrazolium chloride (20) 5-(4~Cyanophenyl)-2,3-diphenyl-2I-I-tetrazolium chloride 30 (21) 3-(p-Acetamidophenyl)-2,5-diphenyl-2H--tetrazolium chloride 5~
(22) 5-Acetyl-2,3-diphenyl-2H-tetrazolium chloride (23) 5-(Fur 2-yl)-2,3-diphenyl-2H-tetrazolium chloride (24) 5-(Thien-2-yl)-2J3-diphenyl-2H-tetrazolium chloride (25) 2,3-Diphenyl-5-(pyrid-~-yl)-2~I-tetrazolium nitrate (26) 2,3-Diphenyl-5-(quinol-2-yl)-2H-tetrazolium chloride (27) 2,3-Diphenyl-5 (benzoxazol-2-yl)-2H-tetrazolium chloride (28) 2,3-Diphenyl-5-nitro-2H-tetrazolium methylsulfate (29) 2,2',3,3'-Tetraphenyl-5,5'-1,4-butylene-di-(2H-tetrazolium chloride) ~ :-(30) 2,2',3,3'-~etraphenyl-5,5'-p-phenylene di-(2H-tetrazolium ;
chloride) (31) 2-(4,5-Dimethylthiazol-2-yl)-3,5-diphenyl-2H-tetrazolium chloride (32) 3,5-Diphenyl-2-(triazin-2-yl)-2H-tetrazolium sulfate (33) 2-(Benzothiazol-2-yl)-3-(4-methoxyphenyl)-5-phenyl-2H-tetrazolium chloride (34) 2,5-Diphenyl-3-~-napthyl-2H-tetrazolium chloride (35) 3,3'-(3,3'-Dimethoxy-4,4'-diphenylene)-2,2',5,5'- ;~
tetraphenyl-di-(2H-tetrazolium chloride) (36) 5-(3-Methoxyphenyl)-3-(3-trif1.uoromethylphenyl)-2-phenyl-2~-tetrazolium acetate --[2] Non diffusible tetrazolium compound (37) 2-(Benzothiazol-2-yl)-3-phenyl-5-dodecyl-2H-tetrazolium bromide (38) 2,3-Diphenyl-5-(4-t-octyloxyphenyl)-2H-tetrazolium chloride (39) 2,3,5-Triphenyl-2H-tetrazolium diethylhexylsuccinate sulfonate (40) 2,3,5-Tri(p-carboxyethylphenyl)-2H-tetrazolium p-dodecyl-benzenesulEonate $
(413 2-(Benzothiazol-2-yl)-3-phenyl-5-(o-chlorophenyl)-2H-tetrazolium diethylhexylsuccinate sulfonate (42) 2,3-Diphenyl-2H-tetrazolium p-octylbenzenesulfonate (43) 2,3-Diphenyl-5-methyl-211-tetrazolium l`aurylsulfate (44) 3-(p-Hydroxyphenyl)-5-methyl-2-phenyl-2H-tetrazolium isopropylnaphthalenesulfonate (45) 2,3-Diphenyl-5-ethyl-2H-tetrazolium diethylhexylsulfo-succinate (46) 2,3-Diphenyl-5-n-hexyl-2H-tetrazolium cetylpolyethenoxy-sulfate (47) 5-Cyano-2,3-diphenyl-2H-tetrazolium polyacrylate (48) 2-(Benzothiazol-2-yl)-5-phenyl-3-(4-tolyl)-2H-tetrazolium diethylhexylsuccinate sulfonate (49) 2-(Benzothiazol-2-yl)-5-(4-chlorophenyl)-3-(~-nitrophenyl)-2H-tetrazolium diethylhexylsuccinate sulfonate (50) 5-Ethoxycarbonyl-2,3-di(3-nitrophenyl)-2H-tetrazolium diethylhexylsuccinate sulfonate (51) 5-Acetyl-2,3-di(p-ethoxyphenyl)-2H-tetrazolium die~hyl-hexylsuccinate sulfonate (52) 2,5-Diphenyl-3-(p-tolyl)-2H-tetrazolium p-octylbenzene sulfonate --(533 2,5-Diphenyl-3-(p-iodophenyl)-2H-tetrazolium p-octyl-benzenesulfonate `
(54) 2,3-Diphenyl-5-(p-diphenyl)-2~1-tetrazolium p-octyl-benzenesulfonate (55) 5-(p-Bromophenyl)-2-phenyl-3-(2,4,6-trichlorophenyl)-2H-tetrazolium isopropylnaphthalenesulfonate (56) 3-(p-Hydxoxyphenyl)-5-(p-nitrophenyl)-2-phenyl-2H-tetrazolium diethylhexylsuccinate sulfonate (57) 5-(3,4-Dimethoxyphenyl)-3-(2 ethoxyphenyl)-2-(4-methoxy-phenyl)-2H-tetrazolium diethylhexylsuccinate sulfonate (58) 5-(4-Cyanophenyl)-2,3-diphenyl-2H-tetrazolium diethyl-hexylsuccinate sulfonate (S9) 3-(p-Acetamidophenyl)-2,5-diphenyl-2H-tetrazolium laurylsulfate (60) 5-Acetyl-2,3-diphenyl-2H-tetrazolium diethylhexyl- -succinate sulfonate (61) 5-(Fur-2-yl)-2,3-diphenyl-2H-tetrazolium diethylhexyl-succinate sulfonate :
(62) 5-(Thien-2-yl)-2,3-diphenyl-2H-tetrazolium diethylhexyl-succinate sulfonate (63) 2,3-Diphenyl-5-(pyrid-4-yl)-2H-tetrazolium diethylhexyl succinate sulfonate (64) 2,3-Diphenyl-5-(quinol-2-yl)-2H-tetrazolium diethylhexylsuccinate sulfonate (65) 2,3-Diphenyl-5-(benzoxazol-2-yl)-2H-tetrazolium diethylhexylsuccinate sulfonate (66) 2,4-Diphenyl-S-nitro-2H-tetrazolium polyacrylate (67) 2,2',3,3'-Tetraphenyl-5,5'~1,4-butylene-di-(2H-tetrazolium) laurylsulfate .
(68) 2,2',3,3'-Tetraphenyl-5,5'-p-phenylene-di-(2H-tetrazolium) cetylpolyethenoxysulfate (69) 2-(4,5-Dimethylthiazol-2-yl)-3,5-diphenyl-2H-tetrazolium polyacrylate (70) 3,5-Diphenyl-2-(triazin-2-yl)-2H-tetrazolium stearate (71) 2-(Benzothiazol-2-yl)-3~(4-methoxyphenyl)-5-phenyl-2H-tetrazolium di-ethylhexylsulfosuccinate (72) 2,5-Diphenyl-3-~-naphtyl-2H-tetrazolium dodecylsulfate (73) 3,3'-(3,3'-Dimethoxy-4t4'-diphenylene)-2,2'5,5'-tetraphenyl~di-(2'-tetrazolium polyacrylate) (74) 5-(3-Methyloxyphenyl)-3-(3-trifluoromethylphenyl)-2-phenyl-te-trazolium isopropylnaphthalenesulfonate (75) 2,3,5-Triphenyl-2H-tetrazolium isopropylnaphthalene-sulfonate The non-diffusible or diffusible tetrazolium compounds according to the invention are thus synthesized by an optional selection of the anionic and cationic moieties. The non-diffusible compounds, e.g. 2,3,5-triphenyl-2H-tetrazolium dioctyl-succinate-sulfonate may dispersed into a gelatin solution by mixing the respective soluble tetrazolium salt and the gelatin first to disperse them in the gelatin solution and then by that optimum anion is admixed thereto thereby to obtain the gelatin solution dispersed with the non-diffusible, tetrazolium compound as specifically mentioned in working Examples set forth lates.
Alternatively, crystals of the non-diffusible tetra-zolium compound purely synthesized may be dissolved in a suitable solvent such as dimethylsulfoxide and then dispersed in the gelatin solution.
When the dispersion is not sufficiently homogeneous, good results may be obtained by exposing the emulslon dispersion to an ultrasonic wave or by use of a suitable homogenizer such as Manton-Gaulin homogenizer.
As mentionea above, the tetrazolium compounds of this invention may be used both in diffusible and non-diffusible orms, when the silver halide of this invention is employed. However, the higher contrast image may be obtained by employing the non-diffusible tetrazolium compounds. Accordingly, it is advantageous to employ the non-diffusible tetrazolium compound when an especially superior dot quality is required.
On the other hand, the use of too much high contrast light-sensitive material sometimes brings about not sufficient reproduction o~ the line-image, particularly those of fine letters and lines. In this case, an image with more superior quality may be obtained by the use of the diffusible tetrazolium compounds.
According to a preferred embodiment of the invention, the tetrazolium compound of the invention is incorporated into a silver halide emulsion layer.
According to another preferred embodiment oE the invention, the compound is incorporated in a layer adjacent -directly (or a layer adjacent to said adjacent layer) to the layer containing the silver halide emulsion.
The above-mentioned compounds of the invention may preferably be employed in an amount of 0.0001 - 10 mole, more preferably 0.001 - 1 mole, per mole of the silver halide contained in the light-sensitive silver halide photographic material of the inven-tion.
The sensitizing dyes used in this invention mean those which can extend a sensitive wave length range of the silver halide outside of its inherent sensitive wave length. Sensitiz ing dyes used ~or this invention cover those such as cyanines, merocyanines, hemicyanines, oxonols, hemioxonols or mixed mero-cyanines. Such dyes are described in e.g. "The cyanine dye and related compounds" by F. M. ~lamer and "The Theory of Photographic Process", Third edition by C. E. Kenneth Mees and T. ~1. James.
The sensitizing dyes of this invention may be concretely expressed by the general formulae LIV~XJ;
^l- - 15 , ,:
~IV,~: " - Z 1 R~ N~=ClI-CH )ml C Ll~L2_L3~--C~CH-CH~j~N-R2 (X~
fvl: z Q- l Rl-N ( CH=CHt~j~~ C~' 0~ :~
~VI~: ", Z1 N ~ CH CH ) m C ~Ll-L2 ~ C
R -~)N~CH-CH~ C~L1 2~;~
(~) Q-1 Q~1 /C L1 ( L2 L3 ) n1 C~ Q2 O I H
,.
2 0 fIX,~: ,~' ", ~/~\~
Q~l ~,C Ll+L2=L3~;~
~o ~X7: " Z
R1-N~CH=CH~C~L1-L2~ IC \F L1~ 2 3 ~- 2 "
--C=~=CH-CH~ R2 ( ) Q-l r-~ ~ 16 ~ .
5~8~
In which Rl, R2 and R3 each represent an alkyl group ~e.g. methyl, ethyl, propyl, butyl and substituted alkyl such as chloroethyl, hydroxyethyl, methoxyethyl, acetoxy-ethyl, carhoxymethyl, carboxyethyl, ethoxycarbonylme-thyl, sulfoethyl, sulfopropyl, sulfobutyl, ~-hydroxy-~-sulfo-propyl, sulfatepropyl, allyl, benzyl, etc.) or an aryl group (e.g. phenyl, carboxyphenyl, sulfophenyl, etc.);
Ll, L2 and L3 each represent a methynyl group including substituted methynyl (e.g. -CH=, -C(C~I3)=, -C(C2H5)=, -c(cll2cooH)=r -C(CH2~ )=, -c (C6H5)=, -C(C6N4COOH)=~
etc.); Zl' Z2 and Z3 each represent an atom or atom groups necessary Eor forming a 5 to 6 membered heterocyclic ring (e.g. thiazoline, oxazoline, selenazoline, thiazole, selenazole, oxazole, benzothiazole, benzooxazole, benzo-quinazole, benzoimidazole, 3,3-dialkyl-indolenine, naphtho-thiazole, naphthooxazole, naphthoselenazole, thienothiazole, 2-pyridine, 4-pyridine, 2-quinoline, 4-quinoline nucleus etc.); P and Q each represent cyano, -COOR4, -COR4 or -SO2R~
in which R4 represents an alkyl group; ~urther Ql and Q2 each represent an atomic group necessary for forming a thiooxazolone ring, a pyrazolone ring, an oxyindole ring, a barbituric acid, a 2 thiobarbituric acid, a 2,4-oxazoli- ;
dinedione ring, a 2,4-thiazolidinedione ring, a 2,4-imida-zolidinedione ring, a 2-thio-2,4-oxazolidinedione ring, a 2-thio-2,4-thiazolidinedione ring, a 2-thio-2,4-selena-zolidinedione ring, a 2-thio-2,5-thiazolidinedione ring, a 2-thiohydantoine ring, a 4-oxazolinone ring, a 4-thia- ;~
zolinone ring or a 4-imidazoline ring, etc., the groups or rings including the substituted; Y represents hydrogen, amino, alkylamino preferably having 1 to 4 carbon atoms ~s~
(e.g. ethylamino, etc.), dialkylamino preferably having 2 to 8 carbon atoms (e.g. dimethylamino, etc.), halogen (e g. chlorine or bromine atom, etc.) or an alkyl group preferably having 1 to 4 carbon atoms (e.g. methyl, etc.);
ml and m2 each represent zero or 1; nl and n2 each represent 0 or 2; X represents an acid anion (e.g. CQ~ , Br~ , ~ , CQ04~ , CH3 ~ S03~ -, C~13S04 ~ C2~15S4 etc.); Q represents 1 or 2 and an intramolecular salt is formed when Q represents 1.
Typical sensitizing dyes having the above general formulae according to this invention will be exemplified below but this is not intended to limit these dyes:
CH = <
(CH2)3S03 C2 5 ~ ~ ~ CH = <
(CII2)3S03 (Cll2)3s '~ < ~D
`
5~
4 ~ S e ~D
CH3 (CII2)3SO~
5. CH3 ~ ~ CH=C - CH= < N --3 CH
6. 12 5 ~ ~-/~ \ N '~ n / c ~
cQ (1H2~2COO (CH2)2COOH
~ ~ -C~l=C - CH=<
(CH2)3SO3 (CH2)3SO3H N
8. C~I3 N ~ CH=C - CI-I=<
(CH2)3SO3 (C 2)3 3 _ 19 ~
Q ~ ~ CH=C-- CH= < ,~
~CH2) 4S0(~) (CE12) 4S03Na 10 .
~ S 1 2.H5 5 ~
I~J (1 2) 3 3 (1H2) 3S03H N (C2 5 3 11. C2H5 --~ CH=CH-CH= / --N N /~ (~
C H ( CH 2 ) 3 S0(~
12 .
J~ CII= -- CH=<
(C 2) 3 3 (CH2) 3S03H-N~3 ,~CN=C ----CH= ~ ~--C
(C~12) 3SO3 (C112) 3S03H N~ ~
C~ ::
14. C2H5 f2H5 C~ ~ N N ~ ~C~Q
~ I ~CH=CH-CH= ~ li C,2 J~J~ ~?, N--~ 1 ` C_~
f~ (CH2) 2CHS03Na (CH2) 2CHs3C113 15. CH3 CH3 CH= [~lC~=< _ 2 5 I(~)C2H5 2 0 16 . Cn CH=CH-6~ oe ¦~ ~J~
17 .
~X > -"~ >=S
O
c2~5 C2~15 CH3-N ~ ~ ~ 5 1 9 . ~ :
CH-CH ~ ~ S
10 20. CH~CH20H
CH-CH ~ > S
1 2 3 ~ :
503Na ;~1.
~ CH-CH=CH-CH~ S
: 20 C2H5 CH2CooH
`:
22. :~
CH=CH ~ -N < 3 C2~5 ~ :
CH-3 ~ SO~
~: :
~ ' - -- 22 - ~
:` ~ : , ` :` i: ,: .
5~
23 .
>CCH-CHcCH-CH lS ~, 24. ;
C2H5-N~=CU C =~ >=CH~
O H C2H5 CH3~;~SO (3 25 .
~-S
CH 2--CH=CH 2 20 26. - -¢~ )=CH-C-- CH~ ~r(3 , C2H5 C2H5 27 .
~LCH~
.
28.
U CH=CH ~ ~r~
29.
~CH-CH~
C2~5 ~ '~
CH2-CH=CH2 These compounds of this invention can readily be synthesized by the methods described in e.g. U. S. Patents 2,213,995, 3,711,288, 2,503,776, 3,576,641, 2,945,763, 3,625,6.98, etc..
These sensitizing dyes according to this invention may be incorporated into a hydrophilic colloid containing the silver halide of this invention and a tetrazolium compound by dissolving them in water or an organic solvent such as methanol and ethanol, which is miscible with water in any ratio and they can be used in single or in combination of two or more.
The incorporation of the sensitizing dyes into said hydrophilic colloid may be any time during the preparation of the silver halide emulsion, but is preferred to be generally after the completion of the second ripening.
The sensitizing dye can be used in an amount of 10 mg to 1 g~ preferably 30 to 300 mg, per one mole of silver halide.
The iight-sensitive silver halide photographic material of this invention, in which the sensitizing dye is incorporated, can shown not only an excellent stability during development but ~$~
also can be sensitized in any preferred spectrum range. In addition, a super sensitization can be expected by use of a combination of two or more sensitizing dyes in general.
~s the silver halide employed for the light-sensitive silver halide photographic material of the invention, there can be included silver halide used for the conventional silver halide photographic materials, e.g. silver bromide, silver chlorobromide, silver iodobromide, silver chloroiodobromide or silver chloride and the like. The average grain size of the silver halide in the inven-tion is 0.05 - 1.5 ~, preferably 0.1 -0.8 ~, and at least 75% grains of the total grains are within a range of 0.6 - 1.4, preferably 0.7 - 1.3 times larger than the average grain size. Furthermore, the silver halide comprises ;
silver chlorobromide or chloroiodobromide containing at least 50 mole % silver chloride. The silver halide of the invention hav-ing the above-mentioned average grain size and the distribution thereof may be prepared by any known method described, e.g. in , U.S. Patents 2,592,250, 3,276,877, 3,317,322, 2,222,264, 3,320,069 and 3,206,313 and in Journal of Photographic Science 12(5), 242-251 (1964). Silver halides prepared by other methods may also be employed in mixture.
According to the most preferred concrete embodiment of the invention, the silver halide of the invention is silver chloroiodobromide or chlorobromide having an average grain size of 0.1 - 0.5 ~ and at least 80~ grains of the total grains being within a range of 0.7 - 1.3 times larger than the average grain size.
The silver halide emulsion of the invention may be sensitized with various kinds of chemical sensitizers. ~s the sensitizer, there can be mentioned, for example, activated -gelatin, sulfur sensitizers (e.g. sodium thiosulfate, aryl thiocarbamide, thiourea or aryl isocyanate, etc.), selenium -sensitizers (e.g. N,N-dimethylserenourea or selenourea, etc.), reducing sensitizers (e.g. triethylenetetramine or stannic chloride, etc.) and various noble metal sensitizers represen-ted by potassium chloroaurite, potassium auriothiocyanate, potassium chloroaurate, 2-aurosulfobenzothiazole methylchloride, ammonium chloropalladate, potassium chloroplatinate and sodium chloro-palladite. The sensitizer may be employed alone, or mixed together. Ammonium thiocyanate may be auxiliarily employed when a gold sensitizer is employed.
The silver halide emulsion of the invention may preferably be stabilized with 5,6-trimethylene-7-hydroxy-s-triazolo(l,5-a3pyrimidine, 5,6-tetramethylene-7-hydroxy- 9-triazolo(l,5 a)pyrimidine, 5-methyl-7-hydroxy-s-triazolo-(1,5-a)pyrimidine, 7-hydroxy-s-triazolo(1,5-a)pyrimidine, 5-methyl-6-bromo-7 hydroxy-s-triazolo(1,5-a)pyrimidine, esters or salts of gallic acid (e.g. isoamyl gallate, dodecyl gallate, propyl gallate or sodium gallate), mercaptans (e.g. 1-phenyl-5-mercaptotetrazole or 2-mercaptobenzothiazole), benzotriazoles (e.g. 5-bromobenzotriazole or 4-methylbenzotriazole) and benzimidazoles ~e.g. 6-nitrobenzimidazole). Such stabilizers are described in, e.g. U.S. Patents 2,444,607, 2,716,062, 3,512,982, 3,34~,596l 3,726,686 and 3,717,465, British Patent 1,363,921. Furthermore, the silver halide emulsion of the invention may contain a latent image stabilizer such as a sulfur-containing amino acid, or a gradation-adjusting agent such as a cadmium or rhodium salt, described in, e.g. British Patent 1,343,904 and U.S. Patent 3,821,295 ~ ~ 55~3~
It has been known in, e.g. British Patent 775,197 and U.S. Patent 3,488~709, to employ a rhodium or cadmium salt to increase the contrast of silver halide emulsion. However, problems still remain when the rhodium salt is employedO For example, the use of rhodium salt kends to cause an unevenness of the product due to the minute amount of addition and the narrow allowable range thereo~ of the salt, and thus makes it difficult to produce stable photographic material. In case of the cadmium salt, it has to be added as little as possible from an ecological viewpoint, for it is washed out by film-processing and comes finally in~o the environment. The cadmium salts are ~`
known to prevent the metabolism and to be harmful to living tissues. Cadmium may be detected not only in air but also in the body of sea animals. As a result of interest in public health and in the maintenance of normal ecological balance in view of the toxicity o~ rare metals, including cadmium mentioned above, the inventors have reached the invention relating to a novel method to obtain a light-sensitive material with su~fi~ -ciently high contrast, even in no use of such harmful metals when the above-mentioned silver halide, tetrazolium compound and sensitizing dye of the invention are incorporated into the hydrophilic colloidal layer.
The hydrophilic colloid advantageously employed in the invention is gelatin. As other hydrophilic colloids than gelatin, are mentioned, e.g. colloidal albumin, agar, gum arabic arginic acid, hydrolyzed cellulose acetate,acrylamide, imidated polyamide, polyvinyl alcohol, hydrolized polyvinyl acetate, water-soluble polymer described in, e.g~ British Patent 523,661, U.S. Patents 3,847,620, 3,655,389 and 3,341f332, gelatin derivatives such as phenylcarbamyI-, acylated- or phthalated-gelatin described in, e.g. U.S. Patents 2,614,928 and 2,525,753, or graft-polymerized monomers on gelatin having the ethylene group and being capable of polym~rization, such as acrylic acid and the ester thereof, styrene, a methacrylic acid and -the ester thereof, described in, e.g. U.S. Patents 2,548,520 and 2,831,767.
Such hydrophilic colloids may also be applied to a layer contain-~ing no silver halide, e.g. an antihalation layer, a protective layer or a intermediate layer.
The light-sensitive silver halide material of the invention may be prepared by coating the above-mentioned layer containing the silver halide, the sensitizing dye and the tetra-zolium compound of the invention on a suitable photographic support. As the representative supports employed in the invention are mentioned, e.g. a baryta paper, a polyethylene-coated paper, a synthetic polypropylene paper, a glass plate, a cellulose acetate or cellulose nitrate film, a polyester film such as a polyethylene terephthalate film, a polyamide film, a polypropylene film, a polycarbonate film, a polystyrene film and the li]ce. The supports are`optionally selected depending on the purpose for which the light-sensitive photographic material is used.
As mentioned above, the light-sensitive silver-halide photographic material of the invention comprise at least one hydrophilic colloidal layer, coated on a support, containing a silver halide o the invention and a sensitizing dye and a tetrazolium compound.
It is preferable in the light-sensitive material of the invention that a protective layer having a suitable thickness is coated. The protective layer is advantageously a gelatin layer, the thickness of which is preferably 0.1 - 10 ~, more preferably 0.8 2.0 ~.
~.
~9i ~ ?~
The presence of the protective layer may act effec-tively on the stability of the image quality and of the developing process in this invention. This is presumed because, the protective layer may have a function to control adequately the iniltration rate of the hydroquinone/Metol or phenidone from the processing solution into the light-sensitive material, or the diffusion rate of the tetrazolium compound within the light-sensitive material or therefrom to the process-ing solution. This efect is remarkable when the tetrazolium compound of the invention is employed. The effect is not so remarka~lewhenother oxidizing agents than the tetrazolium com-pound, aescribed in, e.g. German Patent Application D.O.S.
2634666 published on February 7, 1977, are employed.
Various kinds of photographic additives may optionally be added to the above-mentioned hydrophilic colloid of the invention, as far as they do not impair the effect of the invention. As the additives, there can be used, e.g. a gelatin plasticizer, a hardening agent, a surface active agent, a image stabilizer, an ultraviolet absorber, an anthistaining agent, a pH adjuster, an antioxidant, an antistatic agent, a viscosity-increasing agent, a granularity improving agentl a dye, a mordant, a brightening agent, a development regulator, a matting agent, and the like.
Among the additives mentioned above, the following may particularly and prefPrably be employed: viscosity-increasing agents and plasticizers, described in U.S. Patents 2,960,404 and 3,767,410, 3,659,~56 and 3,692,753, e.g. a styrene/sodium maleate copolymer and dextran sulfate~ etc.; hardening agents of an aldehyde, epoxy, ethyleneimine, active halogen, vinylsulfone, isocyanate, sulfonic acid ester, carbodiimide, mucochloric acid ~ 29 -.
5~
or acryloyls, etc.; image stabilizers, e.g. 6,6'-butylidene-bis(2~t-butyl-4-methylphenol) and 4,4'-methylene-bis(2,6-di-t-butylphenol), etc.; ultraviolet absorbers, described in, e.g.
U.S. Patent 3,253,921, British Patent 1,309,349, U.S~ Patents 3,533,794 and 3,707,375 and British Patent 1,287,770, particu larly 2-(2-hydroxy-5-t-butylphenyl)benzotriazole, 2-(2-hydroxy-3,5-di-t-butylphenyl~benzotriazole, 2-(2-hydroxy-3-t-butyl-5-butylphenyl)-5-chlorobenzotriazole and 2-(2-hydroxy-3,5-di-t-butylphenyl)-5-chlorobenzotriazole; surface active agents or coating aids, emulsifiers, infiltration-improving agents for processing solution, defoamers, or agents for controlling various physical proper~ies of the light-sensitive material, described in, e.g. U.S. Patents 3,026,202 and 3,514,293, British Patents 548,532 and 1,216,389, U.S. Patent 3,726,683, including anionic,cationic, nonionic and amphoteric compounds; mordants described in, e.g.
U.S. Patents 2,113,381 and 2,548,564; antistaining agents described in, e.g. U.S. Patents 2,360,210, 2,728,659, 2,732,300 and 3,700,453, particularly 2-methyl-5-hexadecylhydroquinone, 2-methyl-5-sec-octadecylhydroquinone and 2,5-di-t-octylhydro-quinone, etc.; antistatic agents described in, e.g. U.S. Patents2,882,157, 2j972,535 and 3,573,093 and British Patent 1j378,584 and U.S. Patents 3,549,369, 3,704,128 and 3,663,230; matting agents described in, e.g. U.S. Patents ~,992,101 and 2,956,884, British Patent 1,221,980 and British Patent 1,307,373,particu-larly silica gel having a grain size of 0.5 - 20 ~ and poly-- methylmethacrylate having a grain size of 0.5 - ~0 ~; developing promotors, e.g. benzyl alcohol and a polyoxyethylene series compoùnd which may be added in the processing bath.
In accordance with the process of the invention, there is obtained a high contrast silver image. The lnvention is ~ - 30 -there~ore applicable to various fields wherein a high contrast black and white recording is required. The light-sensitive material of the invention is, for example, applied preferably to a printing- or micro- sensitive material. The process of the invention for forming a lith type photographic image has superior characteristics which no conventional processes have reached yet. It is not necessarily elucidated why the high contrast silver image may be obtained according to the process of the invention. It is presumed that the semiquinone produced by oxidation of hydroquinone in the developing solution by the tetrazolium compound may be accumulated in an abnormally high concentration near the developed silver. It is said, in general, that the so-called "infectious phenomenon" does not take place due to instantaneous removal of the semiquinone or quinones by sulfonation when the sulfite ions are in a high concentration in the developing solution. Whereas, in the present process, it is presumed as if the infectious development takes place at the position of the exposed silver halide in the gelatin layer due to predominant supply of the semiquinone.
It is accordingly essential in the process of the invention to treat with a developing solution containing a hydroquinones developing agent. The lith type developing solution (infectious developing solution), however, is not essentially required as far as the solution is oE hydroquinones by which high contrast lith type silver image may sufficiently be obtained even in the presence o~ sulfite ion in a high concentration. The process of the invention differs apparently from the conventional processes in that no conventional lith type developing solution which contains hydroquinone, alkali, alkali metal bromide, sulfite ion in low concentration, and as a preserver a condensation product of formaldehyde/sodium bisulfite or carbonylbissulfite amine is neededr although the use of such components may of course be possible.
As the hydroquinone type developing agents employed in the invention are mentioned, e.g. hydroquinone, chloro-hydxoquinone, bromohydroquinone, isopropylhydroquinone, tolu-hydroquinone, methylhydroquinone, 2,3-dichlorohydroquinone, 2,5-dimethylhydroquinone, 2,3-dibromohydroquinone, 2,5-dihydroxyacetophenone, 2,5-diethylhydroquinone, 2,5-di~p-phenethylhydroquinone, 2,5-dibenzoylaminohydroquinone, and the like.
The developing solution containing the hydroquinones developing agent employed in the invention includes not only the so-called lith type developing agent but also the gradient MQ
and PQ developing solution, the latters of which are advantage-ously employed in the invention because of the easiness of preparation and superior preservability. Among these developing solutions, those which show the superadditivity are preferred.
For example, the developing agents and the additives therefor described in "The Theory of Photographic Process", Third Edition, pp 374-378 (1966) are advantageously employed. A preserver like sulfite salts such as sodium sulfite, potassium sulfite or ammonium sulfite may jointly be employed in the developing solution used in the invention without impairing the effect of the invention; and this is another characteristic of the invention.
The adjustment of pH and giving a bufer function with an alkali hydroxide, alkali carbonate or amine, or addition of inorganic development retarder such as potassium bromide or of organic development retarder such as benzotriazole may optionally be carried out as in the standard black and white developing solution.
;i5~
In the invention the phrase "treat with a developing solution containing hydroquinones developing agent" means to -carry out development of the exposed material of the invention with the developing solution which satisfies the above-mentioned conditions, and various modes may be included therein. For example, the temperature at which development is carried out is preferably below 50C, more preferably around 30C, and the time required for devèlopment is generally within 30 minutes, more preferably within 5 minutes, by which good results are obtained, in general.
Ater the development, the subsequent processes such as washing, stopping, stabilizing and fixing are carried out.
If necessary, processes like prehardening and neutralization and the like may be adopted, but they may optionally be omitted.
The processes may be carried out either by the so-called manual treatment like a bath- or tray-development or by the mechanical treatment like a roller- or hanger-development. ~ccording to a preferred embodiment of the invention, the processing solution in the bath development was more than 20 times more stabler over long period than the conventional lith type developing solution.
Especially, when the known particular developing sol~tion containing-sulfite ion in an extremely low concentration is employed in order to improve the dot quality of the lith type light-sensitive material, it became of no use for several hours.
While, according to a preferred method of the invention, the processing solution could be stably employed after one month has passed, and the dot quality using the solution was then comparable to that using a newly prepared solution.
Furthermore, addition of a contrast agent often used for the conventional high contrast developing solution to _ 33 _ .
the developing solution employed in the invention gives no undesirable in1uence on the photographic quality.
As can be clearly understood by the explanations given above, the invention relates to a novel light-sensitive silver halide photographic material and the processing method thereof which may obtain a superior stable line- or dot image by processing the light-sensitive silver halide photographic material comprising a sensitizing dye, a tetrazolium salt and a silver halide having a narrow grain size distribution, with a developing solution containing hydroquinone, using no infectio~s developing solution.
According to the process of the invention, there is obtained a stable high con~rast silver image even when the diffusible tetrazolium compound is employed. There may also be obtained a stable dot image which is superior to that obtained by the method described in German Patent Application D.O.S. 2634666 published on ~ebruary 7, 1977, when the non-diffusible tetrazolium compound is employed.
The invention is further concretely explained by the following Examples, which by no means restrict the scope of the invention and various many modified embodiments may be possible: .
Example l A silver chlorobromide-gelation emulsion in fine grain size state containing silver halide of 90 mole ~ of silver chlo-ride, 9 mole % of silver bromide and 1 mole % of silver iodide was chemically sensitized with a sulfur and gold sensitizing agent. This emulsion had an average grain size of 0.25 ~ and 75% of the whole grains were within a range of 0.19 to 0.31 in grain size. To this emulsion 8 g o 2,3,5-triphenyltetrazolium ~ ~ 3~ ~
chloride per one mole of silver and the equimolar amount of diethylhexylsuccinate sulfonate (hereintoafter, referred to as DES) were added. This emulsion was coated on a polyethylene telephthalate support so as to contain 53 mg of silver/100 cm2 ~nd 50 mg of gelatin/100 cm . Next, this pho-tographic element was wedge-exposed through a gray contact screen of intermediate tone with a tungsten lamp and processed by the following treat-ments at 30C.
Development 1.5 minutes Water washing 1 "
Fixing 2 "
Water washing 5 "
Drying.
The following composition were employed in the processing bath:
[Developing solution~ ~, Metol 3.5 g ~nhydrous sodium sulfite 60 g Hydroquinone 9.0 g Sodium carbonate 54 g Potassium bromide 2.5 g --5-Nitrobenzimidazole 0.5 g l-Phenyl-5-mercapto-tetrazole 10 mg Water to make 1 litre (pH=10 D 25) [Fixing solution]
Ammonium thiosulfate decahydrate 150 mg - Anhydrous sodium sulfite 10 g Sodium acetate trihydrate . 15 g ~5~'~'$
Glacial acetic acid 15 mQ
Water to make 1 liter (pH=6.80) "Dot quality" here in the examples of this invention means an estimated value of reproduced halftone dot images.
Halftone images obtained rom the exposed and then developed lith type light-sensitive photographic material are composed of the part called generally "shadow dot" and the part known as "highlight part". There is an intermediate part of various areas in size between both the ends. "Dot quality" here means an evaluated value of the dot in the part having 50 ~ dot in which a half of a definite area is clear and the rest of it is a developed image and the dot quality is expressed in progressive scale. That is~ 11411 means excellence and "1" extremely badness.
The dot quality below 3 can not be generally permitted.
To this emulsion was incorporated ~xemplified sensitizing dye No. 14 dissolved in methanol in an amount of 200 mg per one mole of silver (Sample 2).
The results obtained are shown in Table 1.
.5~
Table 1 _ Sensitiæing Development Relative F Dot Sample dyetime(s) sensitivity og quality No addition 60 60 0.01 3.0 of the dye 80 100 0.02 3.7 1 (outside of .
this 100 120 0.03 3.3 . invention) 120 130 0.04 3.0 _ _ 0.01 3.3 Compound No. 14 _ 0.02 3.7 2 (within this _ 100 100 0.02 3.7 . invention) . _ 120 110 0.02 3.3 _ Table 1 shows that the light-sensitive material according to this invention does not vary in specific sensitivity and fog with the development time compared with other materials than this invention and the variation of dot quality is also small.
Example 2 A silver halide emulsion was prepared which comprises a silver chlorobromide emulsion containing silver halide of 60 :
mole % of silver chloride and 40 mole % of silver bromide and of which the average grain size is 0.3 ~ and 75% of the whole grains is within a range of 0.24 to 0.37 ~.
To this emulsion hexaamminecobalt (III) trichloride was added in amount of 4.0 g per one mole of silver. After the sensitizing dye No. 10 was added in an amount of 200 mg per one mole of silver, the emulsion was coated on a polyethylene terephthalate support so as to contain 55 mg of silver per 100 cm2 and 30 mg of gelatin per 100 cm2 and dried.
~ 37 - :
.
(Sample 3) Next, a similar sample was prepared as above except that 3.0 g of 2.5-diphenyl-3-~~napthtyltetrazolium chloride (35) was added instead of hexaamminecobalt (III) -trichloxide ~Sample 4) These samples were treated in the same way as in Example 1 together with Sample 5 containing no oxidant.
The results are shown in Table 2.
Table 2 ` :~
Development Relative Fo Dot Sample time(s) sensitivity g quality _ _ Sample 3 60 30 _ 2.0 0.01 2.3 (outside of this 100 80 0.01 2.5 invention) 120 150 0.02 2.0 . 60 80 0.01 2.7 Sample 4 .
100 0.01 3.5 . _ . ~within this 100 110 0.01 3.3 ~:
invention) _ :~
120 130 0.01 3.0 sa~ple 5 60 130 0.03 bad . 80 180 0.07 ." ~"~
(outslde of . _ ._ this ` 100 220 0.10 : :
invention) 120 280 0.20 _ Table 2 shows that Sample 4 of this invention has an excellent dot quality compared with Samples 3 and 5.
Example 3 A silver halide emulsion which comprises a silver bromide emulsion, in which the average grain size is 0.25 ~ and about 75% of the whole grains is within a range of 0.19 to 0O31 ~, was chemically sensitized with a gold sensitizer. Into this emulsion was added 4-hydroxy-6-methyl-1,3,3a,7-tetrazaindene in an amount of 500 mg per one mole of silver. This emulsion was coated on a polyethylene tereph-thalate film supp~rt in an amount of 50 mg of silver per 100 cm2 and dried. In this case, the following compounds were added after chemical ripening to obtain the following samples.
Sample 6: Hexaamminecobalt (III) isopropylnaphthalenesulfonate was added to this emulsion in an amount of 5.0 g per one mole of silver.
Sample 7: Compound No. 12 of the sensitizing dye was added to Sample 6 in an amount of 220 mg per one mole of silver.
Sample 8: This sample was prepared in the same way as in Sample 7 except that 2,3,5-triphenyl-2H-tetrazolium isopropyl-naphthalenesulfonate (tetrazolium Compound (75)) was added in the same mole amount instead of hexaamminecobalt ~III) isopropyl-naphthalenesulfonate.
Sample 9: Tartrazine{4,5-dihydro-5-oxo~ sulfonyl)-4-1(4-sulfonyl)azo~-lH-pyrazole-3-carboxylic acid trisodium salt~
was added to Sample 8 in an amount of 100 mg per one mole of silver.
These samples were treated in the same way as in Example 1 except that they were developed by the following developing solution at 30C for 60, 80, 100, 120 and 140 seconds.
Composition of the developing solution l-~henyl-3-pyrazolidone0.8 g Anhydrous sodium sulfite 45 g Potassium hydroxide10 g Hydroquinone 20 g Anhydrous sodium carbonate - 20 g 6-Nitroindazole 0.1 g Pure water to make 1 Q
The results ohtained are shown in Table 3.
Table 3 Development Relative Dot Sampletime(s) sensitivity og quality ., _ .
0.01 2.0 0.01 3.0 _ Sample 6100 100 0.02 3.2 . _ 120 140 0.03 3.0 ~ :
. 140 170 0.04 2.5 _ 0.01 2.5 _ _ _ .
0.01 3.0 _ Sample 7100 95 0.01 3.5 120 107 0.02 3.7 140 120 0.03 3.0 . .
0.00 3.0 _ 0.01 3.5 Sample 8100 100 0.01 3.8 _ 120 100 0.01 3.8 _ 14-0 103 0.01 - 3.5 _ 0.00 3.0 . _ ..
OoOl3.5 .
Sample 9 100 97 0.01 4.0 _ _ _ ~
120 102 0.01 4.0 _ 140 107 0.01 3.5 _ __ Table 3 shows the following facts: even in the case of using non-diffusible oxidants except the tetrazolium salt, some effects could be expected but the use of the tetrazolium salt .. -- ~0 --, :
produced remarkable effects. The use of an irradiation prohibiting dye such as Tartrazine except the sensitizing dye has some effects for raising the dot quality but has no e~fect for processing stably the development and giving skable characteristics as in this invention.
Example 4 In this example the same emulsion as in Example 3 was used and the following compounds were added after the emulsion was chemically sensitized.
Sample 10: 3-(p-~ydroxyphenyl)-5-methyl-2-phenyl-2H-tetrazolium chloride (tetrazolium Compound (18)) was added in an amount of !
3.0 g per one mole of silver.
Sample 11: To sample 10 was further added Compound No. 23 of the sensitizing dye in amount of 150 mg per one mole of silver.
These sample were treated with the same development process as in Example 1 except that they were developed for 80, 100, 120 and 140 seconds.
The results obtained are shown in Table 4.
Table 4 Sample time(s) sensitivity Fog _ quality 0.004.0 2.0 . , 100 87 0.018.0 2.7 ~ , Sample 10 120 1~0 0.0310.0 3.0 140 135 0.059 3 2.7 _80 0.017.0 2.5 100 100 0.0110.0 3.0 Sample 11 _ _ 120_ 107 ~.0210.0 3.0 _ ~40112 0.039 5 3.0 , .
Table 4 shows that the sample, in which the sensiti~ing dye was added, has a higher stabili~y during the development process than that having no addition.
Example 5 This sample was p~epared in the same way as in Example 4 using the dye compound No. 23 so as to have an average grain size of 0.25 ~ by mixing single diffraction emulsions hav-ing 0.015 ~ and 0.035 ~ at peaks. :
The results obtained are shown in Table 5.
Table 5 _ _ .
Sensitizing Development Relative Fo Dot dye time(s) sensitivity g quality 0.011.5 100 0.022.0 No addition 100 130 0.032.5 ~ :
_ .
120 ` 150 0.04_1.5 _ 0.011.5 :
. 200 mg of Compound .
110 0.022.0 23 was added per one mole of 100 137 0.032.7 silver ~
120 155 0.032.0 ~:
' 2Q Table 5 shows that sufficient effects can not obtained whenthe grain size distribution is wider than the scope of that of this invention. ~:
.
, .. ..
(22) 5-Acetyl-2,3-diphenyl-2H-tetrazolium chloride (23) 5-(Fur 2-yl)-2,3-diphenyl-2H-tetrazolium chloride (24) 5-(Thien-2-yl)-2J3-diphenyl-2H-tetrazolium chloride (25) 2,3-Diphenyl-5-(pyrid-~-yl)-2~I-tetrazolium nitrate (26) 2,3-Diphenyl-5-(quinol-2-yl)-2H-tetrazolium chloride (27) 2,3-Diphenyl-5 (benzoxazol-2-yl)-2H-tetrazolium chloride (28) 2,3-Diphenyl-5-nitro-2H-tetrazolium methylsulfate (29) 2,2',3,3'-Tetraphenyl-5,5'-1,4-butylene-di-(2H-tetrazolium chloride) ~ :-(30) 2,2',3,3'-~etraphenyl-5,5'-p-phenylene di-(2H-tetrazolium ;
chloride) (31) 2-(4,5-Dimethylthiazol-2-yl)-3,5-diphenyl-2H-tetrazolium chloride (32) 3,5-Diphenyl-2-(triazin-2-yl)-2H-tetrazolium sulfate (33) 2-(Benzothiazol-2-yl)-3-(4-methoxyphenyl)-5-phenyl-2H-tetrazolium chloride (34) 2,5-Diphenyl-3-~-napthyl-2H-tetrazolium chloride (35) 3,3'-(3,3'-Dimethoxy-4,4'-diphenylene)-2,2',5,5'- ;~
tetraphenyl-di-(2H-tetrazolium chloride) (36) 5-(3-Methoxyphenyl)-3-(3-trif1.uoromethylphenyl)-2-phenyl-2~-tetrazolium acetate --[2] Non diffusible tetrazolium compound (37) 2-(Benzothiazol-2-yl)-3-phenyl-5-dodecyl-2H-tetrazolium bromide (38) 2,3-Diphenyl-5-(4-t-octyloxyphenyl)-2H-tetrazolium chloride (39) 2,3,5-Triphenyl-2H-tetrazolium diethylhexylsuccinate sulfonate (40) 2,3,5-Tri(p-carboxyethylphenyl)-2H-tetrazolium p-dodecyl-benzenesulEonate $
(413 2-(Benzothiazol-2-yl)-3-phenyl-5-(o-chlorophenyl)-2H-tetrazolium diethylhexylsuccinate sulfonate (42) 2,3-Diphenyl-2H-tetrazolium p-octylbenzenesulfonate (43) 2,3-Diphenyl-5-methyl-211-tetrazolium l`aurylsulfate (44) 3-(p-Hydroxyphenyl)-5-methyl-2-phenyl-2H-tetrazolium isopropylnaphthalenesulfonate (45) 2,3-Diphenyl-5-ethyl-2H-tetrazolium diethylhexylsulfo-succinate (46) 2,3-Diphenyl-5-n-hexyl-2H-tetrazolium cetylpolyethenoxy-sulfate (47) 5-Cyano-2,3-diphenyl-2H-tetrazolium polyacrylate (48) 2-(Benzothiazol-2-yl)-5-phenyl-3-(4-tolyl)-2H-tetrazolium diethylhexylsuccinate sulfonate (49) 2-(Benzothiazol-2-yl)-5-(4-chlorophenyl)-3-(~-nitrophenyl)-2H-tetrazolium diethylhexylsuccinate sulfonate (50) 5-Ethoxycarbonyl-2,3-di(3-nitrophenyl)-2H-tetrazolium diethylhexylsuccinate sulfonate (51) 5-Acetyl-2,3-di(p-ethoxyphenyl)-2H-tetrazolium die~hyl-hexylsuccinate sulfonate (52) 2,5-Diphenyl-3-(p-tolyl)-2H-tetrazolium p-octylbenzene sulfonate --(533 2,5-Diphenyl-3-(p-iodophenyl)-2H-tetrazolium p-octyl-benzenesulfonate `
(54) 2,3-Diphenyl-5-(p-diphenyl)-2~1-tetrazolium p-octyl-benzenesulfonate (55) 5-(p-Bromophenyl)-2-phenyl-3-(2,4,6-trichlorophenyl)-2H-tetrazolium isopropylnaphthalenesulfonate (56) 3-(p-Hydxoxyphenyl)-5-(p-nitrophenyl)-2-phenyl-2H-tetrazolium diethylhexylsuccinate sulfonate (57) 5-(3,4-Dimethoxyphenyl)-3-(2 ethoxyphenyl)-2-(4-methoxy-phenyl)-2H-tetrazolium diethylhexylsuccinate sulfonate (58) 5-(4-Cyanophenyl)-2,3-diphenyl-2H-tetrazolium diethyl-hexylsuccinate sulfonate (S9) 3-(p-Acetamidophenyl)-2,5-diphenyl-2H-tetrazolium laurylsulfate (60) 5-Acetyl-2,3-diphenyl-2H-tetrazolium diethylhexyl- -succinate sulfonate (61) 5-(Fur-2-yl)-2,3-diphenyl-2H-tetrazolium diethylhexyl-succinate sulfonate :
(62) 5-(Thien-2-yl)-2,3-diphenyl-2H-tetrazolium diethylhexyl-succinate sulfonate (63) 2,3-Diphenyl-5-(pyrid-4-yl)-2H-tetrazolium diethylhexyl succinate sulfonate (64) 2,3-Diphenyl-5-(quinol-2-yl)-2H-tetrazolium diethylhexylsuccinate sulfonate (65) 2,3-Diphenyl-5-(benzoxazol-2-yl)-2H-tetrazolium diethylhexylsuccinate sulfonate (66) 2,4-Diphenyl-S-nitro-2H-tetrazolium polyacrylate (67) 2,2',3,3'-Tetraphenyl-5,5'~1,4-butylene-di-(2H-tetrazolium) laurylsulfate .
(68) 2,2',3,3'-Tetraphenyl-5,5'-p-phenylene-di-(2H-tetrazolium) cetylpolyethenoxysulfate (69) 2-(4,5-Dimethylthiazol-2-yl)-3,5-diphenyl-2H-tetrazolium polyacrylate (70) 3,5-Diphenyl-2-(triazin-2-yl)-2H-tetrazolium stearate (71) 2-(Benzothiazol-2-yl)-3~(4-methoxyphenyl)-5-phenyl-2H-tetrazolium di-ethylhexylsulfosuccinate (72) 2,5-Diphenyl-3-~-naphtyl-2H-tetrazolium dodecylsulfate (73) 3,3'-(3,3'-Dimethoxy-4t4'-diphenylene)-2,2'5,5'-tetraphenyl~di-(2'-tetrazolium polyacrylate) (74) 5-(3-Methyloxyphenyl)-3-(3-trifluoromethylphenyl)-2-phenyl-te-trazolium isopropylnaphthalenesulfonate (75) 2,3,5-Triphenyl-2H-tetrazolium isopropylnaphthalene-sulfonate The non-diffusible or diffusible tetrazolium compounds according to the invention are thus synthesized by an optional selection of the anionic and cationic moieties. The non-diffusible compounds, e.g. 2,3,5-triphenyl-2H-tetrazolium dioctyl-succinate-sulfonate may dispersed into a gelatin solution by mixing the respective soluble tetrazolium salt and the gelatin first to disperse them in the gelatin solution and then by that optimum anion is admixed thereto thereby to obtain the gelatin solution dispersed with the non-diffusible, tetrazolium compound as specifically mentioned in working Examples set forth lates.
Alternatively, crystals of the non-diffusible tetra-zolium compound purely synthesized may be dissolved in a suitable solvent such as dimethylsulfoxide and then dispersed in the gelatin solution.
When the dispersion is not sufficiently homogeneous, good results may be obtained by exposing the emulslon dispersion to an ultrasonic wave or by use of a suitable homogenizer such as Manton-Gaulin homogenizer.
As mentionea above, the tetrazolium compounds of this invention may be used both in diffusible and non-diffusible orms, when the silver halide of this invention is employed. However, the higher contrast image may be obtained by employing the non-diffusible tetrazolium compounds. Accordingly, it is advantageous to employ the non-diffusible tetrazolium compound when an especially superior dot quality is required.
On the other hand, the use of too much high contrast light-sensitive material sometimes brings about not sufficient reproduction o~ the line-image, particularly those of fine letters and lines. In this case, an image with more superior quality may be obtained by the use of the diffusible tetrazolium compounds.
According to a preferred embodiment of the invention, the tetrazolium compound of the invention is incorporated into a silver halide emulsion layer.
According to another preferred embodiment oE the invention, the compound is incorporated in a layer adjacent -directly (or a layer adjacent to said adjacent layer) to the layer containing the silver halide emulsion.
The above-mentioned compounds of the invention may preferably be employed in an amount of 0.0001 - 10 mole, more preferably 0.001 - 1 mole, per mole of the silver halide contained in the light-sensitive silver halide photographic material of the inven-tion.
The sensitizing dyes used in this invention mean those which can extend a sensitive wave length range of the silver halide outside of its inherent sensitive wave length. Sensitiz ing dyes used ~or this invention cover those such as cyanines, merocyanines, hemicyanines, oxonols, hemioxonols or mixed mero-cyanines. Such dyes are described in e.g. "The cyanine dye and related compounds" by F. M. ~lamer and "The Theory of Photographic Process", Third edition by C. E. Kenneth Mees and T. ~1. James.
The sensitizing dyes of this invention may be concretely expressed by the general formulae LIV~XJ;
^l- - 15 , ,:
~IV,~: " - Z 1 R~ N~=ClI-CH )ml C Ll~L2_L3~--C~CH-CH~j~N-R2 (X~
fvl: z Q- l Rl-N ( CH=CHt~j~~ C~' 0~ :~
~VI~: ", Z1 N ~ CH CH ) m C ~Ll-L2 ~ C
R -~)N~CH-CH~ C~L1 2~;~
(~) Q-1 Q~1 /C L1 ( L2 L3 ) n1 C~ Q2 O I H
,.
2 0 fIX,~: ,~' ", ~/~\~
Q~l ~,C Ll+L2=L3~;~
~o ~X7: " Z
R1-N~CH=CH~C~L1-L2~ IC \F L1~ 2 3 ~- 2 "
--C=~=CH-CH~ R2 ( ) Q-l r-~ ~ 16 ~ .
5~8~
In which Rl, R2 and R3 each represent an alkyl group ~e.g. methyl, ethyl, propyl, butyl and substituted alkyl such as chloroethyl, hydroxyethyl, methoxyethyl, acetoxy-ethyl, carhoxymethyl, carboxyethyl, ethoxycarbonylme-thyl, sulfoethyl, sulfopropyl, sulfobutyl, ~-hydroxy-~-sulfo-propyl, sulfatepropyl, allyl, benzyl, etc.) or an aryl group (e.g. phenyl, carboxyphenyl, sulfophenyl, etc.);
Ll, L2 and L3 each represent a methynyl group including substituted methynyl (e.g. -CH=, -C(C~I3)=, -C(C2H5)=, -c(cll2cooH)=r -C(CH2~ )=, -c (C6H5)=, -C(C6N4COOH)=~
etc.); Zl' Z2 and Z3 each represent an atom or atom groups necessary Eor forming a 5 to 6 membered heterocyclic ring (e.g. thiazoline, oxazoline, selenazoline, thiazole, selenazole, oxazole, benzothiazole, benzooxazole, benzo-quinazole, benzoimidazole, 3,3-dialkyl-indolenine, naphtho-thiazole, naphthooxazole, naphthoselenazole, thienothiazole, 2-pyridine, 4-pyridine, 2-quinoline, 4-quinoline nucleus etc.); P and Q each represent cyano, -COOR4, -COR4 or -SO2R~
in which R4 represents an alkyl group; ~urther Ql and Q2 each represent an atomic group necessary for forming a thiooxazolone ring, a pyrazolone ring, an oxyindole ring, a barbituric acid, a 2 thiobarbituric acid, a 2,4-oxazoli- ;
dinedione ring, a 2,4-thiazolidinedione ring, a 2,4-imida-zolidinedione ring, a 2-thio-2,4-oxazolidinedione ring, a 2-thio-2,4-thiazolidinedione ring, a 2-thio-2,4-selena-zolidinedione ring, a 2-thio-2,5-thiazolidinedione ring, a 2-thiohydantoine ring, a 4-oxazolinone ring, a 4-thia- ;~
zolinone ring or a 4-imidazoline ring, etc., the groups or rings including the substituted; Y represents hydrogen, amino, alkylamino preferably having 1 to 4 carbon atoms ~s~
(e.g. ethylamino, etc.), dialkylamino preferably having 2 to 8 carbon atoms (e.g. dimethylamino, etc.), halogen (e g. chlorine or bromine atom, etc.) or an alkyl group preferably having 1 to 4 carbon atoms (e.g. methyl, etc.);
ml and m2 each represent zero or 1; nl and n2 each represent 0 or 2; X represents an acid anion (e.g. CQ~ , Br~ , ~ , CQ04~ , CH3 ~ S03~ -, C~13S04 ~ C2~15S4 etc.); Q represents 1 or 2 and an intramolecular salt is formed when Q represents 1.
Typical sensitizing dyes having the above general formulae according to this invention will be exemplified below but this is not intended to limit these dyes:
CH = <
(CH2)3S03 C2 5 ~ ~ ~ CH = <
(CII2)3S03 (Cll2)3s '~ < ~D
`
5~
4 ~ S e ~D
CH3 (CII2)3SO~
5. CH3 ~ ~ CH=C - CH= < N --3 CH
6. 12 5 ~ ~-/~ \ N '~ n / c ~
cQ (1H2~2COO (CH2)2COOH
~ ~ -C~l=C - CH=<
(CH2)3SO3 (CH2)3SO3H N
8. C~I3 N ~ CH=C - CI-I=<
(CH2)3SO3 (C 2)3 3 _ 19 ~
Q ~ ~ CH=C-- CH= < ,~
~CH2) 4S0(~) (CE12) 4S03Na 10 .
~ S 1 2.H5 5 ~
I~J (1 2) 3 3 (1H2) 3S03H N (C2 5 3 11. C2H5 --~ CH=CH-CH= / --N N /~ (~
C H ( CH 2 ) 3 S0(~
12 .
J~ CII= -- CH=<
(C 2) 3 3 (CH2) 3S03H-N~3 ,~CN=C ----CH= ~ ~--C
(C~12) 3SO3 (C112) 3S03H N~ ~
C~ ::
14. C2H5 f2H5 C~ ~ N N ~ ~C~Q
~ I ~CH=CH-CH= ~ li C,2 J~J~ ~?, N--~ 1 ` C_~
f~ (CH2) 2CHS03Na (CH2) 2CHs3C113 15. CH3 CH3 CH= [~lC~=< _ 2 5 I(~)C2H5 2 0 16 . Cn CH=CH-6~ oe ¦~ ~J~
17 .
~X > -"~ >=S
O
c2~5 C2~15 CH3-N ~ ~ ~ 5 1 9 . ~ :
CH-CH ~ ~ S
10 20. CH~CH20H
CH-CH ~ > S
1 2 3 ~ :
503Na ;~1.
~ CH-CH=CH-CH~ S
: 20 C2H5 CH2CooH
`:
22. :~
CH=CH ~ -N < 3 C2~5 ~ :
CH-3 ~ SO~
~: :
~ ' - -- 22 - ~
:` ~ : , ` :` i: ,: .
5~
23 .
>CCH-CHcCH-CH lS ~, 24. ;
C2H5-N~=CU C =~ >=CH~
O H C2H5 CH3~;~SO (3 25 .
~-S
CH 2--CH=CH 2 20 26. - -¢~ )=CH-C-- CH~ ~r(3 , C2H5 C2H5 27 .
~LCH~
.
28.
U CH=CH ~ ~r~
29.
~CH-CH~
C2~5 ~ '~
CH2-CH=CH2 These compounds of this invention can readily be synthesized by the methods described in e.g. U. S. Patents 2,213,995, 3,711,288, 2,503,776, 3,576,641, 2,945,763, 3,625,6.98, etc..
These sensitizing dyes according to this invention may be incorporated into a hydrophilic colloid containing the silver halide of this invention and a tetrazolium compound by dissolving them in water or an organic solvent such as methanol and ethanol, which is miscible with water in any ratio and they can be used in single or in combination of two or more.
The incorporation of the sensitizing dyes into said hydrophilic colloid may be any time during the preparation of the silver halide emulsion, but is preferred to be generally after the completion of the second ripening.
The sensitizing dye can be used in an amount of 10 mg to 1 g~ preferably 30 to 300 mg, per one mole of silver halide.
The iight-sensitive silver halide photographic material of this invention, in which the sensitizing dye is incorporated, can shown not only an excellent stability during development but ~$~
also can be sensitized in any preferred spectrum range. In addition, a super sensitization can be expected by use of a combination of two or more sensitizing dyes in general.
~s the silver halide employed for the light-sensitive silver halide photographic material of the invention, there can be included silver halide used for the conventional silver halide photographic materials, e.g. silver bromide, silver chlorobromide, silver iodobromide, silver chloroiodobromide or silver chloride and the like. The average grain size of the silver halide in the inven-tion is 0.05 - 1.5 ~, preferably 0.1 -0.8 ~, and at least 75% grains of the total grains are within a range of 0.6 - 1.4, preferably 0.7 - 1.3 times larger than the average grain size. Furthermore, the silver halide comprises ;
silver chlorobromide or chloroiodobromide containing at least 50 mole % silver chloride. The silver halide of the invention hav-ing the above-mentioned average grain size and the distribution thereof may be prepared by any known method described, e.g. in , U.S. Patents 2,592,250, 3,276,877, 3,317,322, 2,222,264, 3,320,069 and 3,206,313 and in Journal of Photographic Science 12(5), 242-251 (1964). Silver halides prepared by other methods may also be employed in mixture.
According to the most preferred concrete embodiment of the invention, the silver halide of the invention is silver chloroiodobromide or chlorobromide having an average grain size of 0.1 - 0.5 ~ and at least 80~ grains of the total grains being within a range of 0.7 - 1.3 times larger than the average grain size.
The silver halide emulsion of the invention may be sensitized with various kinds of chemical sensitizers. ~s the sensitizer, there can be mentioned, for example, activated -gelatin, sulfur sensitizers (e.g. sodium thiosulfate, aryl thiocarbamide, thiourea or aryl isocyanate, etc.), selenium -sensitizers (e.g. N,N-dimethylserenourea or selenourea, etc.), reducing sensitizers (e.g. triethylenetetramine or stannic chloride, etc.) and various noble metal sensitizers represen-ted by potassium chloroaurite, potassium auriothiocyanate, potassium chloroaurate, 2-aurosulfobenzothiazole methylchloride, ammonium chloropalladate, potassium chloroplatinate and sodium chloro-palladite. The sensitizer may be employed alone, or mixed together. Ammonium thiocyanate may be auxiliarily employed when a gold sensitizer is employed.
The silver halide emulsion of the invention may preferably be stabilized with 5,6-trimethylene-7-hydroxy-s-triazolo(l,5-a3pyrimidine, 5,6-tetramethylene-7-hydroxy- 9-triazolo(l,5 a)pyrimidine, 5-methyl-7-hydroxy-s-triazolo-(1,5-a)pyrimidine, 7-hydroxy-s-triazolo(1,5-a)pyrimidine, 5-methyl-6-bromo-7 hydroxy-s-triazolo(1,5-a)pyrimidine, esters or salts of gallic acid (e.g. isoamyl gallate, dodecyl gallate, propyl gallate or sodium gallate), mercaptans (e.g. 1-phenyl-5-mercaptotetrazole or 2-mercaptobenzothiazole), benzotriazoles (e.g. 5-bromobenzotriazole or 4-methylbenzotriazole) and benzimidazoles ~e.g. 6-nitrobenzimidazole). Such stabilizers are described in, e.g. U.S. Patents 2,444,607, 2,716,062, 3,512,982, 3,34~,596l 3,726,686 and 3,717,465, British Patent 1,363,921. Furthermore, the silver halide emulsion of the invention may contain a latent image stabilizer such as a sulfur-containing amino acid, or a gradation-adjusting agent such as a cadmium or rhodium salt, described in, e.g. British Patent 1,343,904 and U.S. Patent 3,821,295 ~ ~ 55~3~
It has been known in, e.g. British Patent 775,197 and U.S. Patent 3,488~709, to employ a rhodium or cadmium salt to increase the contrast of silver halide emulsion. However, problems still remain when the rhodium salt is employedO For example, the use of rhodium salt kends to cause an unevenness of the product due to the minute amount of addition and the narrow allowable range thereo~ of the salt, and thus makes it difficult to produce stable photographic material. In case of the cadmium salt, it has to be added as little as possible from an ecological viewpoint, for it is washed out by film-processing and comes finally in~o the environment. The cadmium salts are ~`
known to prevent the metabolism and to be harmful to living tissues. Cadmium may be detected not only in air but also in the body of sea animals. As a result of interest in public health and in the maintenance of normal ecological balance in view of the toxicity o~ rare metals, including cadmium mentioned above, the inventors have reached the invention relating to a novel method to obtain a light-sensitive material with su~fi~ -ciently high contrast, even in no use of such harmful metals when the above-mentioned silver halide, tetrazolium compound and sensitizing dye of the invention are incorporated into the hydrophilic colloidal layer.
The hydrophilic colloid advantageously employed in the invention is gelatin. As other hydrophilic colloids than gelatin, are mentioned, e.g. colloidal albumin, agar, gum arabic arginic acid, hydrolyzed cellulose acetate,acrylamide, imidated polyamide, polyvinyl alcohol, hydrolized polyvinyl acetate, water-soluble polymer described in, e.g~ British Patent 523,661, U.S. Patents 3,847,620, 3,655,389 and 3,341f332, gelatin derivatives such as phenylcarbamyI-, acylated- or phthalated-gelatin described in, e.g. U.S. Patents 2,614,928 and 2,525,753, or graft-polymerized monomers on gelatin having the ethylene group and being capable of polym~rization, such as acrylic acid and the ester thereof, styrene, a methacrylic acid and -the ester thereof, described in, e.g. U.S. Patents 2,548,520 and 2,831,767.
Such hydrophilic colloids may also be applied to a layer contain-~ing no silver halide, e.g. an antihalation layer, a protective layer or a intermediate layer.
The light-sensitive silver halide material of the invention may be prepared by coating the above-mentioned layer containing the silver halide, the sensitizing dye and the tetra-zolium compound of the invention on a suitable photographic support. As the representative supports employed in the invention are mentioned, e.g. a baryta paper, a polyethylene-coated paper, a synthetic polypropylene paper, a glass plate, a cellulose acetate or cellulose nitrate film, a polyester film such as a polyethylene terephthalate film, a polyamide film, a polypropylene film, a polycarbonate film, a polystyrene film and the li]ce. The supports are`optionally selected depending on the purpose for which the light-sensitive photographic material is used.
As mentioned above, the light-sensitive silver-halide photographic material of the invention comprise at least one hydrophilic colloidal layer, coated on a support, containing a silver halide o the invention and a sensitizing dye and a tetrazolium compound.
It is preferable in the light-sensitive material of the invention that a protective layer having a suitable thickness is coated. The protective layer is advantageously a gelatin layer, the thickness of which is preferably 0.1 - 10 ~, more preferably 0.8 2.0 ~.
~.
~9i ~ ?~
The presence of the protective layer may act effec-tively on the stability of the image quality and of the developing process in this invention. This is presumed because, the protective layer may have a function to control adequately the iniltration rate of the hydroquinone/Metol or phenidone from the processing solution into the light-sensitive material, or the diffusion rate of the tetrazolium compound within the light-sensitive material or therefrom to the process-ing solution. This efect is remarkable when the tetrazolium compound of the invention is employed. The effect is not so remarka~lewhenother oxidizing agents than the tetrazolium com-pound, aescribed in, e.g. German Patent Application D.O.S.
2634666 published on February 7, 1977, are employed.
Various kinds of photographic additives may optionally be added to the above-mentioned hydrophilic colloid of the invention, as far as they do not impair the effect of the invention. As the additives, there can be used, e.g. a gelatin plasticizer, a hardening agent, a surface active agent, a image stabilizer, an ultraviolet absorber, an anthistaining agent, a pH adjuster, an antioxidant, an antistatic agent, a viscosity-increasing agent, a granularity improving agentl a dye, a mordant, a brightening agent, a development regulator, a matting agent, and the like.
Among the additives mentioned above, the following may particularly and prefPrably be employed: viscosity-increasing agents and plasticizers, described in U.S. Patents 2,960,404 and 3,767,410, 3,659,~56 and 3,692,753, e.g. a styrene/sodium maleate copolymer and dextran sulfate~ etc.; hardening agents of an aldehyde, epoxy, ethyleneimine, active halogen, vinylsulfone, isocyanate, sulfonic acid ester, carbodiimide, mucochloric acid ~ 29 -.
5~
or acryloyls, etc.; image stabilizers, e.g. 6,6'-butylidene-bis(2~t-butyl-4-methylphenol) and 4,4'-methylene-bis(2,6-di-t-butylphenol), etc.; ultraviolet absorbers, described in, e.g.
U.S. Patent 3,253,921, British Patent 1,309,349, U.S~ Patents 3,533,794 and 3,707,375 and British Patent 1,287,770, particu larly 2-(2-hydroxy-5-t-butylphenyl)benzotriazole, 2-(2-hydroxy-3,5-di-t-butylphenyl~benzotriazole, 2-(2-hydroxy-3-t-butyl-5-butylphenyl)-5-chlorobenzotriazole and 2-(2-hydroxy-3,5-di-t-butylphenyl)-5-chlorobenzotriazole; surface active agents or coating aids, emulsifiers, infiltration-improving agents for processing solution, defoamers, or agents for controlling various physical proper~ies of the light-sensitive material, described in, e.g. U.S. Patents 3,026,202 and 3,514,293, British Patents 548,532 and 1,216,389, U.S. Patent 3,726,683, including anionic,cationic, nonionic and amphoteric compounds; mordants described in, e.g.
U.S. Patents 2,113,381 and 2,548,564; antistaining agents described in, e.g. U.S. Patents 2,360,210, 2,728,659, 2,732,300 and 3,700,453, particularly 2-methyl-5-hexadecylhydroquinone, 2-methyl-5-sec-octadecylhydroquinone and 2,5-di-t-octylhydro-quinone, etc.; antistatic agents described in, e.g. U.S. Patents2,882,157, 2j972,535 and 3,573,093 and British Patent 1j378,584 and U.S. Patents 3,549,369, 3,704,128 and 3,663,230; matting agents described in, e.g. U.S. Patents ~,992,101 and 2,956,884, British Patent 1,221,980 and British Patent 1,307,373,particu-larly silica gel having a grain size of 0.5 - 20 ~ and poly-- methylmethacrylate having a grain size of 0.5 - ~0 ~; developing promotors, e.g. benzyl alcohol and a polyoxyethylene series compoùnd which may be added in the processing bath.
In accordance with the process of the invention, there is obtained a high contrast silver image. The lnvention is ~ - 30 -there~ore applicable to various fields wherein a high contrast black and white recording is required. The light-sensitive material of the invention is, for example, applied preferably to a printing- or micro- sensitive material. The process of the invention for forming a lith type photographic image has superior characteristics which no conventional processes have reached yet. It is not necessarily elucidated why the high contrast silver image may be obtained according to the process of the invention. It is presumed that the semiquinone produced by oxidation of hydroquinone in the developing solution by the tetrazolium compound may be accumulated in an abnormally high concentration near the developed silver. It is said, in general, that the so-called "infectious phenomenon" does not take place due to instantaneous removal of the semiquinone or quinones by sulfonation when the sulfite ions are in a high concentration in the developing solution. Whereas, in the present process, it is presumed as if the infectious development takes place at the position of the exposed silver halide in the gelatin layer due to predominant supply of the semiquinone.
It is accordingly essential in the process of the invention to treat with a developing solution containing a hydroquinones developing agent. The lith type developing solution (infectious developing solution), however, is not essentially required as far as the solution is oE hydroquinones by which high contrast lith type silver image may sufficiently be obtained even in the presence o~ sulfite ion in a high concentration. The process of the invention differs apparently from the conventional processes in that no conventional lith type developing solution which contains hydroquinone, alkali, alkali metal bromide, sulfite ion in low concentration, and as a preserver a condensation product of formaldehyde/sodium bisulfite or carbonylbissulfite amine is neededr although the use of such components may of course be possible.
As the hydroquinone type developing agents employed in the invention are mentioned, e.g. hydroquinone, chloro-hydxoquinone, bromohydroquinone, isopropylhydroquinone, tolu-hydroquinone, methylhydroquinone, 2,3-dichlorohydroquinone, 2,5-dimethylhydroquinone, 2,3-dibromohydroquinone, 2,5-dihydroxyacetophenone, 2,5-diethylhydroquinone, 2,5-di~p-phenethylhydroquinone, 2,5-dibenzoylaminohydroquinone, and the like.
The developing solution containing the hydroquinones developing agent employed in the invention includes not only the so-called lith type developing agent but also the gradient MQ
and PQ developing solution, the latters of which are advantage-ously employed in the invention because of the easiness of preparation and superior preservability. Among these developing solutions, those which show the superadditivity are preferred.
For example, the developing agents and the additives therefor described in "The Theory of Photographic Process", Third Edition, pp 374-378 (1966) are advantageously employed. A preserver like sulfite salts such as sodium sulfite, potassium sulfite or ammonium sulfite may jointly be employed in the developing solution used in the invention without impairing the effect of the invention; and this is another characteristic of the invention.
The adjustment of pH and giving a bufer function with an alkali hydroxide, alkali carbonate or amine, or addition of inorganic development retarder such as potassium bromide or of organic development retarder such as benzotriazole may optionally be carried out as in the standard black and white developing solution.
;i5~
In the invention the phrase "treat with a developing solution containing hydroquinones developing agent" means to -carry out development of the exposed material of the invention with the developing solution which satisfies the above-mentioned conditions, and various modes may be included therein. For example, the temperature at which development is carried out is preferably below 50C, more preferably around 30C, and the time required for devèlopment is generally within 30 minutes, more preferably within 5 minutes, by which good results are obtained, in general.
Ater the development, the subsequent processes such as washing, stopping, stabilizing and fixing are carried out.
If necessary, processes like prehardening and neutralization and the like may be adopted, but they may optionally be omitted.
The processes may be carried out either by the so-called manual treatment like a bath- or tray-development or by the mechanical treatment like a roller- or hanger-development. ~ccording to a preferred embodiment of the invention, the processing solution in the bath development was more than 20 times more stabler over long period than the conventional lith type developing solution.
Especially, when the known particular developing sol~tion containing-sulfite ion in an extremely low concentration is employed in order to improve the dot quality of the lith type light-sensitive material, it became of no use for several hours.
While, according to a preferred method of the invention, the processing solution could be stably employed after one month has passed, and the dot quality using the solution was then comparable to that using a newly prepared solution.
Furthermore, addition of a contrast agent often used for the conventional high contrast developing solution to _ 33 _ .
the developing solution employed in the invention gives no undesirable in1uence on the photographic quality.
As can be clearly understood by the explanations given above, the invention relates to a novel light-sensitive silver halide photographic material and the processing method thereof which may obtain a superior stable line- or dot image by processing the light-sensitive silver halide photographic material comprising a sensitizing dye, a tetrazolium salt and a silver halide having a narrow grain size distribution, with a developing solution containing hydroquinone, using no infectio~s developing solution.
According to the process of the invention, there is obtained a stable high con~rast silver image even when the diffusible tetrazolium compound is employed. There may also be obtained a stable dot image which is superior to that obtained by the method described in German Patent Application D.O.S. 2634666 published on ~ebruary 7, 1977, when the non-diffusible tetrazolium compound is employed.
The invention is further concretely explained by the following Examples, which by no means restrict the scope of the invention and various many modified embodiments may be possible: .
Example l A silver chlorobromide-gelation emulsion in fine grain size state containing silver halide of 90 mole ~ of silver chlo-ride, 9 mole % of silver bromide and 1 mole % of silver iodide was chemically sensitized with a sulfur and gold sensitizing agent. This emulsion had an average grain size of 0.25 ~ and 75% of the whole grains were within a range of 0.19 to 0.31 in grain size. To this emulsion 8 g o 2,3,5-triphenyltetrazolium ~ ~ 3~ ~
chloride per one mole of silver and the equimolar amount of diethylhexylsuccinate sulfonate (hereintoafter, referred to as DES) were added. This emulsion was coated on a polyethylene telephthalate support so as to contain 53 mg of silver/100 cm2 ~nd 50 mg of gelatin/100 cm . Next, this pho-tographic element was wedge-exposed through a gray contact screen of intermediate tone with a tungsten lamp and processed by the following treat-ments at 30C.
Development 1.5 minutes Water washing 1 "
Fixing 2 "
Water washing 5 "
Drying.
The following composition were employed in the processing bath:
[Developing solution~ ~, Metol 3.5 g ~nhydrous sodium sulfite 60 g Hydroquinone 9.0 g Sodium carbonate 54 g Potassium bromide 2.5 g --5-Nitrobenzimidazole 0.5 g l-Phenyl-5-mercapto-tetrazole 10 mg Water to make 1 litre (pH=10 D 25) [Fixing solution]
Ammonium thiosulfate decahydrate 150 mg - Anhydrous sodium sulfite 10 g Sodium acetate trihydrate . 15 g ~5~'~'$
Glacial acetic acid 15 mQ
Water to make 1 liter (pH=6.80) "Dot quality" here in the examples of this invention means an estimated value of reproduced halftone dot images.
Halftone images obtained rom the exposed and then developed lith type light-sensitive photographic material are composed of the part called generally "shadow dot" and the part known as "highlight part". There is an intermediate part of various areas in size between both the ends. "Dot quality" here means an evaluated value of the dot in the part having 50 ~ dot in which a half of a definite area is clear and the rest of it is a developed image and the dot quality is expressed in progressive scale. That is~ 11411 means excellence and "1" extremely badness.
The dot quality below 3 can not be generally permitted.
To this emulsion was incorporated ~xemplified sensitizing dye No. 14 dissolved in methanol in an amount of 200 mg per one mole of silver (Sample 2).
The results obtained are shown in Table 1.
.5~
Table 1 _ Sensitiæing Development Relative F Dot Sample dyetime(s) sensitivity og quality No addition 60 60 0.01 3.0 of the dye 80 100 0.02 3.7 1 (outside of .
this 100 120 0.03 3.3 . invention) 120 130 0.04 3.0 _ _ 0.01 3.3 Compound No. 14 _ 0.02 3.7 2 (within this _ 100 100 0.02 3.7 . invention) . _ 120 110 0.02 3.3 _ Table 1 shows that the light-sensitive material according to this invention does not vary in specific sensitivity and fog with the development time compared with other materials than this invention and the variation of dot quality is also small.
Example 2 A silver halide emulsion was prepared which comprises a silver chlorobromide emulsion containing silver halide of 60 :
mole % of silver chloride and 40 mole % of silver bromide and of which the average grain size is 0.3 ~ and 75% of the whole grains is within a range of 0.24 to 0.37 ~.
To this emulsion hexaamminecobalt (III) trichloride was added in amount of 4.0 g per one mole of silver. After the sensitizing dye No. 10 was added in an amount of 200 mg per one mole of silver, the emulsion was coated on a polyethylene terephthalate support so as to contain 55 mg of silver per 100 cm2 and 30 mg of gelatin per 100 cm2 and dried.
~ 37 - :
.
(Sample 3) Next, a similar sample was prepared as above except that 3.0 g of 2.5-diphenyl-3-~~napthtyltetrazolium chloride (35) was added instead of hexaamminecobalt (III) -trichloxide ~Sample 4) These samples were treated in the same way as in Example 1 together with Sample 5 containing no oxidant.
The results are shown in Table 2.
Table 2 ` :~
Development Relative Fo Dot Sample time(s) sensitivity g quality _ _ Sample 3 60 30 _ 2.0 0.01 2.3 (outside of this 100 80 0.01 2.5 invention) 120 150 0.02 2.0 . 60 80 0.01 2.7 Sample 4 .
100 0.01 3.5 . _ . ~within this 100 110 0.01 3.3 ~:
invention) _ :~
120 130 0.01 3.0 sa~ple 5 60 130 0.03 bad . 80 180 0.07 ." ~"~
(outslde of . _ ._ this ` 100 220 0.10 : :
invention) 120 280 0.20 _ Table 2 shows that Sample 4 of this invention has an excellent dot quality compared with Samples 3 and 5.
Example 3 A silver halide emulsion which comprises a silver bromide emulsion, in which the average grain size is 0.25 ~ and about 75% of the whole grains is within a range of 0.19 to 0O31 ~, was chemically sensitized with a gold sensitizer. Into this emulsion was added 4-hydroxy-6-methyl-1,3,3a,7-tetrazaindene in an amount of 500 mg per one mole of silver. This emulsion was coated on a polyethylene tereph-thalate film supp~rt in an amount of 50 mg of silver per 100 cm2 and dried. In this case, the following compounds were added after chemical ripening to obtain the following samples.
Sample 6: Hexaamminecobalt (III) isopropylnaphthalenesulfonate was added to this emulsion in an amount of 5.0 g per one mole of silver.
Sample 7: Compound No. 12 of the sensitizing dye was added to Sample 6 in an amount of 220 mg per one mole of silver.
Sample 8: This sample was prepared in the same way as in Sample 7 except that 2,3,5-triphenyl-2H-tetrazolium isopropyl-naphthalenesulfonate (tetrazolium Compound (75)) was added in the same mole amount instead of hexaamminecobalt ~III) isopropyl-naphthalenesulfonate.
Sample 9: Tartrazine{4,5-dihydro-5-oxo~ sulfonyl)-4-1(4-sulfonyl)azo~-lH-pyrazole-3-carboxylic acid trisodium salt~
was added to Sample 8 in an amount of 100 mg per one mole of silver.
These samples were treated in the same way as in Example 1 except that they were developed by the following developing solution at 30C for 60, 80, 100, 120 and 140 seconds.
Composition of the developing solution l-~henyl-3-pyrazolidone0.8 g Anhydrous sodium sulfite 45 g Potassium hydroxide10 g Hydroquinone 20 g Anhydrous sodium carbonate - 20 g 6-Nitroindazole 0.1 g Pure water to make 1 Q
The results ohtained are shown in Table 3.
Table 3 Development Relative Dot Sampletime(s) sensitivity og quality ., _ .
0.01 2.0 0.01 3.0 _ Sample 6100 100 0.02 3.2 . _ 120 140 0.03 3.0 ~ :
. 140 170 0.04 2.5 _ 0.01 2.5 _ _ _ .
0.01 3.0 _ Sample 7100 95 0.01 3.5 120 107 0.02 3.7 140 120 0.03 3.0 . .
0.00 3.0 _ 0.01 3.5 Sample 8100 100 0.01 3.8 _ 120 100 0.01 3.8 _ 14-0 103 0.01 - 3.5 _ 0.00 3.0 . _ ..
OoOl3.5 .
Sample 9 100 97 0.01 4.0 _ _ _ ~
120 102 0.01 4.0 _ 140 107 0.01 3.5 _ __ Table 3 shows the following facts: even in the case of using non-diffusible oxidants except the tetrazolium salt, some effects could be expected but the use of the tetrazolium salt .. -- ~0 --, :
produced remarkable effects. The use of an irradiation prohibiting dye such as Tartrazine except the sensitizing dye has some effects for raising the dot quality but has no e~fect for processing stably the development and giving skable characteristics as in this invention.
Example 4 In this example the same emulsion as in Example 3 was used and the following compounds were added after the emulsion was chemically sensitized.
Sample 10: 3-(p-~ydroxyphenyl)-5-methyl-2-phenyl-2H-tetrazolium chloride (tetrazolium Compound (18)) was added in an amount of !
3.0 g per one mole of silver.
Sample 11: To sample 10 was further added Compound No. 23 of the sensitizing dye in amount of 150 mg per one mole of silver.
These sample were treated with the same development process as in Example 1 except that they were developed for 80, 100, 120 and 140 seconds.
The results obtained are shown in Table 4.
Table 4 Sample time(s) sensitivity Fog _ quality 0.004.0 2.0 . , 100 87 0.018.0 2.7 ~ , Sample 10 120 1~0 0.0310.0 3.0 140 135 0.059 3 2.7 _80 0.017.0 2.5 100 100 0.0110.0 3.0 Sample 11 _ _ 120_ 107 ~.0210.0 3.0 _ ~40112 0.039 5 3.0 , .
Table 4 shows that the sample, in which the sensiti~ing dye was added, has a higher stabili~y during the development process than that having no addition.
Example 5 This sample was p~epared in the same way as in Example 4 using the dye compound No. 23 so as to have an average grain size of 0.25 ~ by mixing single diffraction emulsions hav-ing 0.015 ~ and 0.035 ~ at peaks. :
The results obtained are shown in Table 5.
Table 5 _ _ .
Sensitizing Development Relative Fo Dot dye time(s) sensitivity g quality 0.011.5 100 0.022.0 No addition 100 130 0.032.5 ~ :
_ .
120 ` 150 0.04_1.5 _ 0.011.5 :
. 200 mg of Compound .
110 0.022.0 23 was added per one mole of 100 137 0.032.7 silver ~
120 155 0.032.0 ~:
' 2Q Table 5 shows that sufficient effects can not obtained whenthe grain size distribution is wider than the scope of that of this invention. ~:
.
, .. ..
Claims (12)
1. A light-sensitive silver halide photographic material saidmaterial comprising support and at least one hydrophilic colloidal layer coated on said support, said layer containing :
a) silver halide grains having an average grain size of from 0.05 to 1.4 µ at least 75% of said grains being within a range of 0.6 to 1.4 times the average grain size, b) a tetrazolium compound, said tetrazolium compound being selected from the group consisting of the compounds of formula (I), (II) and (III) :
(I) (II) (III ) where r1, r3, R4, R5, R8, R9, Rl0 and Rll each represents an aryl group or a heterocyclic group ; R2, R6 and R7 each repre-sents an aryl group, a heterocyclic group, an alkyl group, hydroxyl, carboxyl or the salt thereof, an amino group, mercapto, nitro or hydrogen; D represents a divalent aromatic group; E
represents an alkylene group, an arylene group or an aralkylene group; X is an anion, said heterocyclic group being selected from the group consisting of a thiadiazolyl, benzothiadiazolyl, oxazolyl, pyrimidinyl, pyridyl and 2,5-dimethyl-thiadiazolyl group; and n is 1 or 2, provided that the tetrazolium compound forms an intramolecular salt when n is l; and c) a sensitizing dye, said sensitizing dye being present in said hydrophilic colloidal layer and being selected from the group consisting of the compounds of general formulae (IV) through (X) : .
(IV):
(V) : (VI):
(VII):
(VIII ):
(IX):
(X): ' wherein Rl, R2 and R3 each represents an alkyl group or an aryl group~ Ll, L2 and L3 each represents a methynyl group, Zl' Z2 and Z3 each represents an atom or atomic group necessary for forming a 5 to 6-membered heterocyclic ring, P and Q each represents cyano, -COOR~, -COR4 or -S02R4 in which R4 represents an alkyl group, Ql and Q2 each represents an atomic group necessary for forming a thiooxazolone ring, a pyrazolone ring, an oxyindole ring, a barbituric acid, a 2-thiobarbituric acid, a 2,4-oxazolidinedione ring, a 2,4-thiaxolidinedlone ring, a 2,4-imidazolidinedione ring, a 2-thio-2,4-oxazolidinedione ring, a 2-thio-2,4-thiazolidinedione ring, 2-thio-2,4-selenazolidinedione ring, a 2-thio-2, 5-thiazolidinedione ring, a 2-thio-hydantoine ring, a 4-oxazolinone ring, a 4-thiazolinone ring or a 4-imida-zoline ring; Y represents hydrogen, amino, alkylamino, dial-kylamino, halogen, an alkoxy group or an alkyl group; ml and m2 each represents 0 or 1; nl and n2 each represents 0 or 2;
X represents an acid anion group; and ? represents 1 or 2 provided that the sensitizing dye compound forms an intramolecular salt when Q is 1.
a) silver halide grains having an average grain size of from 0.05 to 1.4 µ at least 75% of said grains being within a range of 0.6 to 1.4 times the average grain size, b) a tetrazolium compound, said tetrazolium compound being selected from the group consisting of the compounds of formula (I), (II) and (III) :
(I) (II) (III ) where r1, r3, R4, R5, R8, R9, Rl0 and Rll each represents an aryl group or a heterocyclic group ; R2, R6 and R7 each repre-sents an aryl group, a heterocyclic group, an alkyl group, hydroxyl, carboxyl or the salt thereof, an amino group, mercapto, nitro or hydrogen; D represents a divalent aromatic group; E
represents an alkylene group, an arylene group or an aralkylene group; X is an anion, said heterocyclic group being selected from the group consisting of a thiadiazolyl, benzothiadiazolyl, oxazolyl, pyrimidinyl, pyridyl and 2,5-dimethyl-thiadiazolyl group; and n is 1 or 2, provided that the tetrazolium compound forms an intramolecular salt when n is l; and c) a sensitizing dye, said sensitizing dye being present in said hydrophilic colloidal layer and being selected from the group consisting of the compounds of general formulae (IV) through (X) : .
(IV):
(V) : (VI):
(VII):
(VIII ):
(IX):
(X): ' wherein Rl, R2 and R3 each represents an alkyl group or an aryl group~ Ll, L2 and L3 each represents a methynyl group, Zl' Z2 and Z3 each represents an atom or atomic group necessary for forming a 5 to 6-membered heterocyclic ring, P and Q each represents cyano, -COOR~, -COR4 or -S02R4 in which R4 represents an alkyl group, Ql and Q2 each represents an atomic group necessary for forming a thiooxazolone ring, a pyrazolone ring, an oxyindole ring, a barbituric acid, a 2-thiobarbituric acid, a 2,4-oxazolidinedione ring, a 2,4-thiaxolidinedlone ring, a 2,4-imidazolidinedione ring, a 2-thio-2,4-oxazolidinedione ring, a 2-thio-2,4-thiazolidinedione ring, 2-thio-2,4-selenazolidinedione ring, a 2-thio-2, 5-thiazolidinedione ring, a 2-thio-hydantoine ring, a 4-oxazolinone ring, a 4-thiazolinone ring or a 4-imida-zoline ring; Y represents hydrogen, amino, alkylamino, dial-kylamino, halogen, an alkoxy group or an alkyl group; ml and m2 each represents 0 or 1; nl and n2 each represents 0 or 2;
X represents an acid anion group; and ? represents 1 or 2 provided that the sensitizing dye compound forms an intramolecular salt when Q is 1.
2. A light-sensitive silver halide photographic material according to Claim 1 wherein the tetrazolium compound is non-diffusible.
3. A light-sensitive silver halide photographic material according to Claim 1 wherein the tetrazolium compound is diffusible.
4. A light-sensitive silver halide photographic material according to Claim 1 wherein the hydrophilic colloidal layer is a gelatin layer.
5. A light-sensitive silver halide photographic ma-terial according to Claim 1, wherein the silver halide is silver chlorobromide or silver chloroiodobromide containing at least 50 mole % silver chloride and having an average grain size of from 0.1 to 0.5 µ, at least 80% of said grains being within a range 0.7 to 1.3 times the average grain size.
6. A light-sensitive silver halide photographic material according to Claim 1 wherein the light-sensitive silver halide photographic material further comprises an outermost gelatin protective layer having a thickness of from 0.1 to 10 on the hydrophilic colloidal layer.
7. A light-sensitive silver halide photographic material according to Claim 1 wherein the hydrophilic colloidal layer contains the tetrazolium compound.
8. A light-sensitive silver halide photographic material according to Claim 7 wherein the hydrophilic colloidal layer further contains the sensitizing dye.
9. A light-sensitive silver halide photographic material according to Claim 1 wherein the photographic material further comprises a gelatin layer adjacent to the hydrophilic colloidal layer, the gelatin layer containing the tetrazolium compound while the hydrophilic colloidal layer contains the sensitizing dye.
10. A light-sensitive silver halide photographic material according to Claim 1, wherein said sensitizing dye is selected from the group consisting of :
2.
3.
4. 5. 6. 7. 8.
10 .
11 .
12 .
13. 14. 15. 16. 17. 18 .
19 .
20 .
21 .
22 .
23 .
24 .
25 .
26 .
27 .
28 .
and 29 .
2.
3.
4. 5. 6. 7. 8.
10 .
11 .
12 .
13. 14. 15. 16. 17. 18 .
19 .
20 .
21 .
22 .
23 .
24 .
25 .
26 .
27 .
28 .
and 29 .
11. A light-sensitive silver halide photographic material according to Claim l, wherein said tetrazolium compound is selected from the group consisting of :
(1) 2-(Benzothiazol-2-yl)-3-phenyl-5-dodecyl-2H-tetrazolium (2) 2,3-Diphenyl-5-(4-troctyloxyphenyl)-2H-tetrazoliumm (3) 2,3,5-Triphenyl-2H-tetrazolium (4) 2,3,5-Tri-(p-carboxyethylphenyl)-2H-tetrazolium (5) 2-(Benzothiazol-2-yl)-3-phenyl-5-(o-chlorophenyl)--2H-tetrazolium (6) 2,3-Diphenyl-2H-tetrazolium (7) 2,3-Diphenyl-5-methyl-2H-tetrazolium (8) 3-(p-Hydroxyphenyl)-5-methyl-2-phenyl-2H-tetrazoliium (9) 2,3-Diphenyl-5-ethyl-2H-tetrazolium (10) 2,3-Diphenyl-5-n-hexyl-2H-tetrazolium (11) 5-Cyano-2,3-diphenyl-2H-tetrazolium (12) 2-(Benzothiazol-2-yl)-5-phenyl-3-(4-tolyl)-2H-tetrazolium (13) 2-(Benzothiazol-2-yl)-5-(4-chlorophenyl)-3-(4-nitrophenyl)-2H-tetrazolium (14) 5-Ethoxycarbonyl-2,3-di(3-nitrophenyl)-2H-tetrazolium (15) 5-Acetyl-2,3-di(prethoxyphenyl)-2H-tetrazolium (16) 2,5-Diphenyl-3-(p-tolyl)-2H-tetrazolium (17) 2,5-Diphenyl-3-(priodophenyl)-2H-tetrazolium (18) 2,3-Diphenyl-5-(p-diphenyl) 2H-tetrazolium (19) 5-(p-Bromophenyl)-2-phenyl-3-(2,4,6-trichlorophenyl)-2H-tetrazolium (20) 3-(p-Hydroxyphenyl)-5-(p-nitrophenyl)-2-phenyl-2H
tetrazolium (21) 5-(3,4-Dimethoxyphenyl)-3-(2-ethoxyphenyl)-2-(4-methoxy-phenyl)-2H-tetrazolium (22) 5-(4-Cyanophenyl)-2,3-diphenyl-2H-tetrazolium (23) 3-(p-Acetamidophenyl)-2,5 diphenyl-2H-tetrazolium (24) 5-Acetyl-2,3-diphenyl-2H-tetrazolium (25) 5-(Fur-2-yl)-2,3-diphenyl-2H-tetrazolium (26) 5-(Thien-2-yl)-2,3-diphenyl-2H-tetrazolium (27) 2,3-Diphenyl-5-(pyrid-4-yl)-2H-tetrazolium (28) 2,3-Diphenyl-5-(quinol-2-yl)-2H-tetrazolium (29) 2,3-Diphenyl-5-(benzoxazol-2-yl)-2H-tetrazolium (30) 2,3-Diphenyl-5-nitro-2H-tetrazolium (31) 2,2',3,3'-Tetraphenyl-5,5'-1,4-butylene-di-(2H-tetrazolium) (32) 2,2',3,3'-Tetraphenyl 5,5'-p-phenylene-di-(2H-tetrazolium) (33) 2-(4,5-Dimethylthiazol-2-yl)-3,5-diphenyl-2H-tetrazolium (34) 3,5-Diphenyl-2-(triazin 2-yl)-2H-tetrazolium (35) 2-(Benzothiazol-2-yl)-3-(4-methoxyphenyl)-5-phenyl-2H-tetrazolium (36) 2,5-Diphenyl-3-.alpha.-naphthyl-2H-tetrazolium, and (37) 3,3'-(3,3'-Dimethoxy-4,4'-diphenylene)-2,2',5,5'-tetraphenyl-di-(2H-tetrazolium).
(1) 2-(Benzothiazol-2-yl)-3-phenyl-5-dodecyl-2H-tetrazolium (2) 2,3-Diphenyl-5-(4-troctyloxyphenyl)-2H-tetrazoliumm (3) 2,3,5-Triphenyl-2H-tetrazolium (4) 2,3,5-Tri-(p-carboxyethylphenyl)-2H-tetrazolium (5) 2-(Benzothiazol-2-yl)-3-phenyl-5-(o-chlorophenyl)--2H-tetrazolium (6) 2,3-Diphenyl-2H-tetrazolium (7) 2,3-Diphenyl-5-methyl-2H-tetrazolium (8) 3-(p-Hydroxyphenyl)-5-methyl-2-phenyl-2H-tetrazoliium (9) 2,3-Diphenyl-5-ethyl-2H-tetrazolium (10) 2,3-Diphenyl-5-n-hexyl-2H-tetrazolium (11) 5-Cyano-2,3-diphenyl-2H-tetrazolium (12) 2-(Benzothiazol-2-yl)-5-phenyl-3-(4-tolyl)-2H-tetrazolium (13) 2-(Benzothiazol-2-yl)-5-(4-chlorophenyl)-3-(4-nitrophenyl)-2H-tetrazolium (14) 5-Ethoxycarbonyl-2,3-di(3-nitrophenyl)-2H-tetrazolium (15) 5-Acetyl-2,3-di(prethoxyphenyl)-2H-tetrazolium (16) 2,5-Diphenyl-3-(p-tolyl)-2H-tetrazolium (17) 2,5-Diphenyl-3-(priodophenyl)-2H-tetrazolium (18) 2,3-Diphenyl-5-(p-diphenyl) 2H-tetrazolium (19) 5-(p-Bromophenyl)-2-phenyl-3-(2,4,6-trichlorophenyl)-2H-tetrazolium (20) 3-(p-Hydroxyphenyl)-5-(p-nitrophenyl)-2-phenyl-2H
tetrazolium (21) 5-(3,4-Dimethoxyphenyl)-3-(2-ethoxyphenyl)-2-(4-methoxy-phenyl)-2H-tetrazolium (22) 5-(4-Cyanophenyl)-2,3-diphenyl-2H-tetrazolium (23) 3-(p-Acetamidophenyl)-2,5 diphenyl-2H-tetrazolium (24) 5-Acetyl-2,3-diphenyl-2H-tetrazolium (25) 5-(Fur-2-yl)-2,3-diphenyl-2H-tetrazolium (26) 5-(Thien-2-yl)-2,3-diphenyl-2H-tetrazolium (27) 2,3-Diphenyl-5-(pyrid-4-yl)-2H-tetrazolium (28) 2,3-Diphenyl-5-(quinol-2-yl)-2H-tetrazolium (29) 2,3-Diphenyl-5-(benzoxazol-2-yl)-2H-tetrazolium (30) 2,3-Diphenyl-5-nitro-2H-tetrazolium (31) 2,2',3,3'-Tetraphenyl-5,5'-1,4-butylene-di-(2H-tetrazolium) (32) 2,2',3,3'-Tetraphenyl 5,5'-p-phenylene-di-(2H-tetrazolium) (33) 2-(4,5-Dimethylthiazol-2-yl)-3,5-diphenyl-2H-tetrazolium (34) 3,5-Diphenyl-2-(triazin 2-yl)-2H-tetrazolium (35) 2-(Benzothiazol-2-yl)-3-(4-methoxyphenyl)-5-phenyl-2H-tetrazolium (36) 2,5-Diphenyl-3-.alpha.-naphthyl-2H-tetrazolium, and (37) 3,3'-(3,3'-Dimethoxy-4,4'-diphenylene)-2,2',5,5'-tetraphenyl-di-(2H-tetrazolium).
12. A method of processing a light-sensitive silver halide photographic material, as defined in Claim 1, after imagewise exposure to light, comprising the step of treating said material with a developing solution containing a hydro-quinone and Metol or phenidone.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP51091919A JPS5917818B2 (en) | 1976-07-31 | 1976-07-31 | Silver halide photographic material |
| JP91919 | 1976-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1115584A true CA1115584A (en) | 1982-01-05 |
Family
ID=14039980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA283,717A Expired CA1115584A (en) | 1976-07-31 | 1977-07-29 | Light-sensitive silver halide photographic material containing a tetrazolium compound and a sensitizing dye |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS5917818B2 (en) |
| AU (1) | AU499945B2 (en) |
| CA (1) | CA1115584A (en) |
| DE (1) | DE2734335C2 (en) |
| FR (1) | FR2360911A1 (en) |
| GB (1) | GB1589594A (en) |
| SE (1) | SE7708670L (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5917826B2 (en) * | 1977-01-31 | 1984-04-24 | コニカ株式会社 | Processing method for silver halide photographic materials |
| JPS5917822B2 (en) * | 1977-02-01 | 1984-04-24 | コニカ株式会社 | Silver halide photographic material |
| US4455343A (en) * | 1980-12-29 | 1984-06-19 | Ppg Industries, Inc. | Aqueous treating composition for glass fiber strands used to produce mats for thermoplastics |
| JPS58120247A (en) * | 1982-01-11 | 1983-07-18 | Konishiroku Photo Ind Co Ltd | Image formation |
| EP0104555B1 (en) * | 1982-09-24 | 1988-03-09 | Ppg Industries, Inc. | Treated glass fibers for use in an aqueous dispersion to manufacture nonwoven mat |
| JPS5968303A (en) * | 1982-10-12 | 1984-04-18 | Nippon Oil & Fats Co Ltd | Production of aqueous suspension of solid organic peroxide |
| JPS5979244A (en) * | 1982-10-29 | 1984-05-08 | Konishiroku Photo Ind Co Ltd | Formation of silver image |
| FR2579133B1 (en) * | 1985-03-25 | 1987-09-25 | Atochem | FIBER REINFORCED THERMOPLASTIC POLYMER COMPOSITE MATERIAL, MANUFACTURING METHOD THEREOF |
| EP0228084B1 (en) | 1985-12-25 | 1992-03-18 | Fuji Photo Film Co., Ltd. | Image forming process |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE615097A (en) * | 1961-03-14 | |||
| IT984942B (en) * | 1973-05-07 | 1974-11-20 | Minnesota Mining & Mfg | TETRAZOLIO BETAINE C OXES AS ANTI-FROST AGENTS FOR SILVER HALIDE PHOTO GRAPHIC EMULSIONS |
| JPS5917825B2 (en) * | 1975-08-02 | 1984-04-24 | コニカ株式会社 | How to form high contrast silver images |
-
1976
- 1976-07-31 JP JP51091919A patent/JPS5917818B2/en not_active Expired
-
1977
- 1977-07-27 GB GB3145177A patent/GB1589594A/en not_active Expired
- 1977-07-27 AU AU27353/77A patent/AU499945B2/en not_active Expired
- 1977-07-28 SE SE7708670A patent/SE7708670L/en not_active Application Discontinuation
- 1977-07-29 CA CA283,717A patent/CA1115584A/en not_active Expired
- 1977-07-29 DE DE19772734335 patent/DE2734335C2/en not_active Expired
- 1977-08-01 FR FR7723668A patent/FR2360911A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB1589594A (en) | 1981-05-13 |
| DE2734335C2 (en) | 1985-12-19 |
| AU499945B2 (en) | 1979-05-03 |
| JPS5317720A (en) | 1978-02-18 |
| AU2735377A (en) | 1979-02-01 |
| FR2360911A1 (en) | 1978-03-03 |
| SE7708670L (en) | 1978-02-01 |
| DE2734335A1 (en) | 1978-02-02 |
| JPS5917818B2 (en) | 1984-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4169733A (en) | Process for forming high-contrast silver images | |
| US4233400A (en) | Light-sensitive silver halide photographic material containing tetrazolium compounds | |
| US5004669A (en) | Light-sensitive silver halide photographic material | |
| US4268620A (en) | Method of processing of light-sensitive silver halide photographic material | |
| CA1115584A (en) | Light-sensitive silver halide photographic material containing a tetrazolium compound and a sensitizing dye | |
| CA1110484A (en) | Light-sensitive silver halide photographic material containing a tetrazolium compound | |
| CA1331301C (en) | Silver halide photograhic material and method for forming an image | |
| CA1310533C (en) | Process for the formation of high contrast negative images and silver halide photographic element | |
| US4210715A (en) | Light-sensitive silver halide photographic material and method of processing thereof | |
| JPS6290646A (en) | Silver halide photographic sensitive material and image forming method using it | |
| US4211835A (en) | Light-sensitive silver halide photographic material and method of processing the same | |
| US4221864A (en) | Light-sensitive silver halide photographic materials | |
| US4416980A (en) | High-contrast light-sensitive silver halide photographic material | |
| GB1600573A (en) | Process for forming high-contrast silver images | |
| US4820625A (en) | Direct positive silver halide photographic material | |
| EP0295945B1 (en) | Negative silver halide photographic light-sensitive material capable of being handled in light room | |
| US4192682A (en) | Process of forming a high-contrast silver image | |
| US4175966A (en) | Light-sensitive black-white silver halide photographic material for forming a high-contrast silver image and method of treating thereof | |
| US3628958A (en) | Bipyridinium compound/nitrosubstituted n-heterocyclic compound desensitized silver halide emulsion | |
| EP0650086B1 (en) | Method of improving abrasion resistance of photographic silver halide materials | |
| US5342732A (en) | Photographic high contrast silver halide materials | |
| JPS6232777B2 (en) | ||
| JPH04257850A (en) | Direct uv light-sensitive postive halogenated silver photograph material which can be handled in bright room | |
| JPS58207039A (en) | Silver halide photosensitive material and its processing method | |
| EP0351077B1 (en) | Bright safe light handleable high contrast photographic materials |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |